| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.72 | 0.002 | 0.72 | GABA C receptor agonist | 0.715 0.002 DBMET01431 0.327 0.008 DBMET03515 | ||
| 0.718 | 0.002 | 0.718 | Porphobilinogen synthase inhibitor | 0.512 0.003 DBMET01431 0.142 0.022 DBMET03515 | ||
| 0.709 | 0.005 | 0.709 | Platelet antagonist | 0.605 0.006 DBMET01431 0.47 0.017 DBMET03515 | ||
| 0.702 | 0.008 | 0.702 | Cholesterol antagonist | 0.571 0.022 DBMET01431 0.256 0.121 DBMET03515 | ||
| 0.687 | 0.003 | 0.687 | Tyrosine 3 hydroxylase inhibitor | 0.598 0.003 DBMET01431 0.466 0.004 DBMET03515 | ||
| 0.65 | 0.007 | 0.65 | Histamine release inhibitor | 0.589 0.011 DBMET01431 0.457 0.046 DBMET03515 | ||
| 0.646 | 0.006 | 0.646 | 5 Hydroxytryptamine release inhibitor | 0.597 0.011 DBMET01431 0.344 0.121 DBMET03515 | ||
| 0.646 | 0.02 | 0.719 | Cyclophilin D inhibitor | 0.719 0.012 DBMET01431 0.252 0.211 DBMET03515 | DBMET01431 | |
| 0.621 | 0.013 | 0.621 | 5 Hydroxytryptamine release stimulant | 0.612 0.013 DBMET01431 0.348 0.057 DBMET03515 | ||
| 0.63 | 0.032 | 0.63 | Caspase 9 stimulant | 0.577 0.04 DBMET01431 0.289 0.206 DBMET03515 | ||
| 0.592 | 0.02 | 0.668 | Aldehyde oxidase inhibitor | 0.668 0.011 DBMET01431 0.155 0.134 DBMET03515 | DBMET01431 | |
| 0.587 | 0.017 | 0.587 | Vasodilator, peripheral | 0.449 0.041 DBMET01431 0.242 0.133 DBMET03515 | ||
| 0.585 | 0.018 | 0.585 | Antithrombotic | 0.524 0.026 DBMET01431 0.475 0.033 DBMET03515 | ||
| 0.569 | 0.004 | 0.706 | Alpha-N-acetylglucosaminidase inhibitor | 0.706 0.003 DBMET01431 0.441 0.007 DBMET03515 | DBMET01431 | |
| 0.552 | 0.004 | 0.552 | 5 Hydroxytryptamine uptake stimulant | 0.514 0.004 DBMET01431 0.345 0.027 DBMET03515 | ||
| 0.549 | 0.002 | 0.549 | Ferrochelatase inhibitor | 0.49 0.003 DBMET01431 0.316 0.006 DBMET03515 | ||
| 0.547 | 0.004 | 0.547 | Growth hormone agonist | 0.321 0.028 DBMET01431 0.494 0.007 DBMET03515 | ||
| 0.517 | 0.002 | 0.517 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.419 0.004 DBMET01431 0.485 0.003 DBMET03515 | ||
| 0.516 | 0.002 | 0.516 | Triose-phosphate isomerase inhibitor | 0.393 0.003 DBMET01431 0.144 0.022 DBMET03515 | ||
| 0.514 | 0.007 | 0.554 | Anesthetic general | 0.554 0.005 DBMET01431 0.184 0.084 DBMET03515 | DBMET01431 | |
| 0.516 | 0.018 | 0.516 | Apoptosis antagonist | 0.32 0.073 DBMET01431 0.476 0.024 DBMET03515 | ||
| 0.504 | 0.009 | 0.504 | Platelet aggregation inhibitor | 0.361 0.024 DBMET01431 0.175 0.102 DBMET03515 | ||
| 0.5 | 0.01 | 0.525 | Peroxidase inhibitor | 0.525 0.008 DBMET01431 0.477 0.012 DBMET03515 | DBMET01431 | |
| 0.497 | 0.009 | 0.593 | Interleukin agonist | 0.476 0.01 DBMET01431 0.593 0.005 DBMET03515 | DBMET03515 | |
| 0.497 | 0.011 | 0.497 | Psychostimulant | 0.338 0.034 DBMET01431 0.485 0.012 DBMET03515 | ||
| 0.485 | 0.006 | 0.485 | Phospholipase C inhibitor | 0.343 0.015 DBMET01431 0.345 0.014 DBMET03515 | ||
| 0.5 | 0.028 | 0.501 | Calcium channel L-type activator | 0.501 0.027 DBMET01431 0.324 0.137 DBMET03515 | DBMET01431 | |
| 0.481 | 0.017 | 0.481 | Hypoglycemic | 0.477 0.017 DBMET01431 0.245 0.08 DBMET03515 | ||
| 0.47 | 0.012 | 0.521 | Interleukin 2 agonist | 0.521 0.006 DBMET01431 0.467 0.013 DBMET03515 | DBMET01431 | |
| 0.49 | 0.036 | 0.49 | Immunosuppressant | 0.359 0.082 DBMET01431 0.306 0.111 DBMET03515 | ||
| 0.443 | 0.003 | 0.532 | Glutamate decarboxylase inhibitor | 0.532 0.002 DBMET01431 0.342 0.003 DBMET03515 | DBMET01431 | |
| 0.441 | 0.003 | 0.441 | Phenylalanine 4-hydroxylase inhibitor | 0.404 0.003 DBMET01431 0.221 0.005 DBMET03515 | ||
| 0.452 | 0.017 | 0.465 | Hypolipemic | 0.465 0.016 DBMET01431 | DBMET01431 | |
| 0.448 | 0.019 | 0.616 | Superoxide dismutase inhibitor | 0.504 0.013 DBMET01431 0.616 0.006 DBMET03515 | DBMET03515 | |
| 0.437 | 0.009 | 0.453 | Sodium/bile acid cotransporter inhibitor | 0.453 0.007 DBMET01431 0.327 0.056 DBMET03515 | DBMET01431 | |
| 0.427 | 0.005 | 0.451 | Insulin secretagoues | 0.451 0.005 DBMET01431 0.249 0.02 DBMET03515 | DBMET01431 | |
| 0.418 | 0.002 | 0.418 | Aconitate hydratase inhibitor | 0.292 0.002 DBMET01431 0.07 0.018 DBMET03515 | ||
| 0.454 | 0.04 | 0.51 | GABA C receptor rho-3 antagonist | 0.51 0.023 DBMET01431 | DBMET01431 | |
| 0.417 | 0.004 | 0.417 | Succinate dehydrogenase inhibitor | 0.4 0.004 DBMET01431 0.233 0.029 DBMET03515 | ||
| 0.428 | 0.018 | 0.451 | Insulysin inhibitor | 0.387 0.024 DBMET01431 0.451 0.015 DBMET03515 | DBMET03515 | |
| 0.409 | 0.004 | 0.409 | Gastrin inhibitor | 0.396 0.005 DBMET01431 0.318 0.022 DBMET03515 | ||
| 0.392 | 0.005 | 0.392 | Cystathionine beta-synthase inhibitor | 0.346 0.007 DBMET01431 0.158 0.037 DBMET03515 | ||
| 0.385 | 0.003 | 0.385 | Photosensitizer | 0.256 0.005 DBMET01431 0.218 0.01 DBMET03515 | ||
| 0.43 | 0.049 | 0.63 | Toll-Like receptor agonist | 0.63 0.014 DBMET01431 | DBMET01431 | |
| 0.387 | 0.007 | 0.387 | Insulin sensitizer | 0.362 0.008 DBMET01431 0.31 0.014 DBMET03515 | ||
| 0.38 | 0.005 | 0.397 | Phospholipase A2 inhibitor | 0.3 0.014 DBMET01431 0.397 0.005 DBMET03515 | DBMET03515 | |
| 0.379 | 0.006 | 0.456 | Cell adhesion inhibitor | 0.398 0.005 DBMET01431 0.456 0.005 DBMET03515 | DBMET03515 | |
| 0.377 | 0.004 | 0.834 | Prostaglandin antagonist | 0.834 0.003 DBMET01431 | DBMET01431 | |
| 0.374 | 0.004 | 0.62 | Glutamate dehydrogenase inhibitor | 0.268 0.006 DBMET01431 0.62 0.002 DBMET03515 | DBMET03515 | |
| 0.39 | 0.028 | 0.434 | Calcium channel activator | 0.434 0.014 DBMET01431 | DBMET01431 | |
| 0.369 | 0.007 | 0.369 | Neurotrophic factor enhancer | 0.303 0.017 DBMET01431 0.156 0.129 DBMET03515 | ||
| 0.384 | 0.024 | 0.457 | Angiogenesis stimulant | 0.262 0.065 DBMET01431 0.457 0.015 DBMET03515 | DBMET03515 | |
| 0.39 | 0.032 | 0.591 | Interleukin antagonist | 0.404 0.03 DBMET01431 0.591 0.013 DBMET03515 | DBMET03515 | |
| 0.36 | 0.004 | 0.36 | Alcohol dehydrogenase inhibitor | 0.236 0.009 DBMET01431 0.182 0.014 DBMET03515 | ||
| 0.392 | 0.038 | 0.392 | Vasodilator, coronary | 0.335 0.063 DBMET01431 0.287 0.099 DBMET03515 | ||
| 0.371 | 0.017 | 0.439 | Non-steroidal antiinflammatory agent | 0.439 0.01 DBMET01431 0.156 0.107 DBMET03515 | DBMET01431 | |
| 0.405 | 0.058 | 0.633 | Toll-Like receptor 7 agonist | 0.633 0.014 DBMET01431 | DBMET01431 | |
| 0.344 | 0.004 | 0.344 | Prostaglandin EP2 antagonist | 0.334 0.004 DBMET01431 | ||
| 0.338 | 0.002 | 0.338 | Fumarate hydratase inhibitor | 0.196 0.003 DBMET01431 0.082 0.007 DBMET03515 | ||
| 0.388 | 0.053 | 0.496 | Immunostimulant | 0.329 0.071 DBMET01431 0.496 0.03 DBMET03515 | DBMET03515 | |
| 0.396 | 0.064 | 0.412 | Transcription factor NF kappa B inhibitor | 0.412 0.061 DBMET01431 0.29 0.1 DBMET03515 | DBMET01431 | |
| 0.337 | 0.009 | 0.337 | Aldehyde dehydrogenase inhibitor | 0.252 0.018 DBMET01431 | ||
| 0.371 | 0.045 | 0.371 | Lipoxygenase inhibitor | 0.309 0.067 DBMET01431 | ||
| 0.339 | 0.013 | 0.339 | Protein kinase stimulant | 0.222 0.034 DBMET01431 | ||
| 0.329 | 0.004 | 0.594 | Alcohol oxidase inhibitor | 0.594 0.003 DBMET01431 0.09 0.021 DBMET03515 | DBMET01431 | |
| 0.341 | 0.018 | 0.435 | Thrombolytic | 0.249 0.034 DBMET01431 0.435 0.008 DBMET03515 | DBMET03515 | |
| 0.329 | 0.009 | 0.329 | DNA polymerase I inhibitor | 0.159 0.044 DBMET01431 | ||
| 0.436 | 0.118 | 0.578 | Antiinflammatory | 0.578 0.06 DBMET01431 | DBMET01431 | |
| 0.323 | 0.006 | 0.37 | Adenylate kinase inhibitor | 0.37 0.004 DBMET01431 0.155 0.025 DBMET03515 | DBMET01431 | |
| 0.324 | 0.009 | 0.324 | Cholesterol synthesis inhibitor | 0.314 0.01 DBMET01431 | ||
| 0.318 | 0.003 | 0.318 | Biliverdin reductase inhibitor | 0.282 0.004 DBMET01431 0.121 0.014 DBMET03515 | ||
| 0.343 | 0.032 | 0.36 | DNA synthesis inhibitor | 0.306 0.041 DBMET01431 0.36 0.028 DBMET03515 | DBMET03515 | |
| 0.314 | 0.005 | 0.314 | Phosphofructokinase-1 inhibitor | 0.263 0.007 DBMET01431 0.131 0.022 DBMET03515 | ||
| 0.323 | 0.015 | 0.323 | Bone formation stimulant | 0.242 0.026 DBMET01431 0.249 0.025 DBMET03515 | ||
| 0.324 | 0.017 | 0.324 | Interferon gamma antagonist | 0.285 0.022 DBMET01431 0.275 0.024 DBMET03515 | ||
| 0.308 | 0.003 | 0.308 | GABA aminotransferase inhibitor | 0.208 0.004 DBMET01431 0.153 0.007 DBMET03515 | ||
| 0.301 | 0.003 | 0.301 | Glutamate (mGluR3) antagonist | 0.19 0.004 DBMET01431 0.194 0.003 DBMET03515 | ||
| 0.35 | 0.052 | 0.35 | Spasmolytic | 0.311 0.066 DBMET01431 0.204 0.116 DBMET03515 | ||
| 0.301 | 0.005 | 0.301 | Catenin beta inhibitor | 0.271 0.008 DBMET01431 0.261 0.009 DBMET03515 | ||
| 0.311 | 0.021 | 0.311 | Melanin inhibitor | 0.21 0.037 DBMET01431 0.139 0.099 DBMET03515 | ||
| 0.294 | 0.005 | 0.333 | Integrin antagonist | 0.333 0.005 DBMET01431 0.326 0.005 DBMET03515 | DBMET01431 | |
| 0.31 | 0.021 | 0.31 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.305 0.022 DBMET01431 0.194 0.077 DBMET03515 | ||
| 0.294 | 0.005 | 0.354 | Cell adhesion molecule inhibitor | 0.298 0.005 DBMET01431 0.354 0.005 DBMET03515 | DBMET03515 | |
| 0.301 | 0.019 | 0.301 | Protein-tyrosine phosphatase inhibitor | 0.264 0.027 DBMET01431 0.197 0.048 DBMET03515 | ||
| 0.327 | 0.048 | 0.327 | DNA damaging | 0.229 0.093 DBMET01431 0.187 0.127 DBMET03515 | ||
| 0.299 | 0.021 | 0.299 | Lipocortins synthesis antagonist | 0.255 0.032 DBMET01431 | ||
| 0.28 | 0.007 | 0.345 | Catalase inhibitor | 0.318 0.005 DBMET01431 0.345 0.005 DBMET03515 | DBMET03515 | |
| 0.364 | 0.091 | 0.364 | 15-Lipoxygenase inhibitor | 0.291 0.138 DBMET01431 | ||
| 0.277 | 0.004 | 0.277 | Sphingosine 1-phosphate receptor 5 agonist | 0.203 0.004 DBMET01431 | ||
| 0.277 | 0.005 | 0.385 | Peroxisome proliferator-activated receptor gamma agonist | 0.385 0.004 DBMET01431 | DBMET01431 | |
| 0.275 | 0.005 | 0.275 | Carbamoyl phosphate synthetase inhibitor | 0.207 0.007 DBMET01431 0.187 0.008 DBMET03515 | ||
| 0.274 | 0.005 | 0.274 | TRPA1 agonist | 0.2 0.01 DBMET01431 | ||
| 0.322 | 0.054 | 0.322 | Antioxidant | 0.252 0.082 DBMET01431 0.199 0.114 DBMET03515 | ||
| 0.27 | 0.003 | 0.27 | Sphingosine 1-phosphate receptor 4 agonist | 0.228 0.004 DBMET01431 0.102 0.024 DBMET03515 | ||
| 0.29 | 0.024 | 0.347 | Diuretic | 0.269 0.028 DBMET01431 0.347 0.017 DBMET03515 | DBMET03515 | |
| 0.269 | 0.004 | 0.269 | HIV-1 integrase (Overall Integration) inhibitor | 0.269 0.004 DBMET01431 0.102 0.053 DBMET03515 | ||
| 0.281 | 0.02 | 0.281 | Monophenol monooxygenase inhibitor | 0.203 0.032 DBMET01431 0.097 0.079 DBMET03515 | ||
| 0.264 | 0.004 | 0.264 | Prolactin inhibitor | 0.195 0.009 DBMET01431 0.12 0.039 DBMET03515 | ||
| 0.269 | 0.011 | 0.364 | Aminopeptidase B inhibitor | 0.265 0.011 DBMET01431 0.364 0.005 DBMET03515 | DBMET03515 | |
| 0.267 | 0.01 | 0.267 | Neurotrophic factor | 0.115 0.104 DBMET01431 0.17 0.044 DBMET03515 | ||
| 0.275 | 0.022 | 0.32 | Amylase inhibitor | 0.32 0.016 DBMET01431 0.104 0.093 DBMET03515 | DBMET01431 | |
| 0.3 | 0.048 | 0.3 | Vasodilator | 0.192 0.111 DBMET01431 | ||
| 0.284 | 0.033 | 0.288 | DNA methylase inhibitor | 0.279 0.035 DBMET01431 0.288 0.031 DBMET03515 | DBMET03515 | |
| 0.254 | 0.005 | 0.322 | Vanilloid 1 agonist | 0.209 0.01 DBMET01431 0.322 0.004 DBMET03515 | DBMET03515 | |
| 0.253 | 0.004 | 0.29 | Aminopeptidase I inhibitor | 0.222 0.005 DBMET01431 0.29 0.003 DBMET03515 | DBMET03515 | |
| 0.251 | 0.004 | 0.251 | Adenylate cyclase stimulant | 0.216 0.008 DBMET01431 0.178 0.028 DBMET03515 | ||
| 0.278 | 0.035 | 0.278 | DNA methyltransferase I inhibitor | 0.272 0.037 DBMET01431 0.177 0.082 DBMET03515 | ||
| 0.246 | 0.003 | 0.246 | GABA B receptor agonist | 0.188 0.004 DBMET01431 0.098 0.018 DBMET03515 | ||
| 0.247 | 0.005 | 0.256 | Folate antagonist | 0.139 0.027 DBMET01431 0.256 0.005 DBMET03515 | DBMET03515 | |
| 0.245 | 0.004 | 0.316 | DOPA decarboxylase inhibitor | 0.316 0.002 DBMET01431 0.164 0.015 DBMET03515 | DBMET01431 | |
| 0.245 | 0.004 | 0.245 | Sphingosine 1-phosphate receptor 2 antagonist | 0.204 0.007 DBMET01431 0.133 0.067 DBMET03515 | ||
| 0.251 | 0.012 | 0.251 | Cathepsin G inhibitor | 0.23 0.014 DBMET01431 0.226 0.014 DBMET03515 | ||
| 0.279 | 0.04 | 0.314 | Platelet adhesion inhibitor | 0.314 0.03 DBMET01431 0.277 0.041 DBMET03515 | DBMET01431 | |
| 0.257 | 0.02 | 0.335 | Neurotensin receptor agonist | 0.235 0.024 DBMET01431 0.335 0.011 DBMET03515 | DBMET03515 | |
| 0.241 | 0.005 | 0.241 | Sphingosine 1-phosphate receptor 4 antagonist | 0.216 0.007 DBMET01431 0.11 0.095 DBMET03515 | ||
| 0.368 | 0.132 | 0.434 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.434 0.073 DBMET01431 | DBMET01431 | |
| 0.237 | 0.002 | 0.237 | Glutamate (mGluR6) antagonist | 0.15 0.004 DBMET01431 0.11 0.008 DBMET03515 | ||
| 0.244 | 0.01 | 0.361 | Toll-Like receptor 2 antagonist | 0.208 0.02 DBMET01431 0.361 0.004 DBMET03515 | DBMET03515 | |
| 0.241 | 0.008 | 0.257 | Arachidonic acid antagonist | 0.257 0.004 DBMET01431 | DBMET01431 | |
| 0.243 | 0.009 | 0.468 | Histidine decarboxylase inhibitor | 0.468 0.003 DBMET01431 0.359 0.005 DBMET03515 | DBMET01431 | |
| 0.241 | 0.01 | 0.241 | Carbonic anhydrase III inhibitor | 0.2 0.016 DBMET01431 0.107 0.055 DBMET03515 | ||
| 0.279 | 0.05 | 0.341 | Cyclic AMP phosphodiesterase inhibitor | 0.341 0.028 DBMET01431 | DBMET01431 | |
| 0.233 | 0.005 | 0.233 | Leukotriene antagonist | 0.162 0.009 DBMET01431 | ||
| 0.233 | 0.005 | 0.242 | Electrolyte absorption antagonist | 0.242 0.005 DBMET01431 | DBMET01431 | |
| 0.304 | 0.077 | 0.304 | 12-Lipoxygenase inhibitor | 0.259 0.104 DBMET01431 | ||
| 0.233 | 0.006 | 0.233 | Argininosuccinate synthase inhibitor | 0.231 0.006 DBMET01431 0.232 0.006 DBMET03515 | ||
| 0.231 | 0.005 | 0.236 | Sphingosine 1-phosphate receptor 5 antagonist | 0.236 0.004 DBMET01431 | DBMET01431 | |
| 0.229 | 0.004 | 0.307 | NMDA receptor agonist | 0.238 0.004 DBMET01431 0.307 0.003 DBMET03515 | DBMET03515 | |
| 0.242 | 0.018 | 0.242 | Protein-tyrosine phosphatase 1B inhibitor | 0.2 0.029 DBMET01431 0.135 0.053 DBMET03515 | ||
| 0.274 | 0.059 | 0.274 | Free radical scavenger | 0.24 0.073 DBMET01431 0.212 0.088 DBMET03515 | ||
| 0.218 | 0.007 | 0.218 | Caspase 3 inhibitor | 0.152 0.027 DBMET01431 0.208 0.008 DBMET03515 | ||
| 0.213 | 0.004 | 0.213 | Glycine receptor agonist | 0.151 0.007 DBMET01431 0.068 0.06 DBMET03515 | ||
| 0.209 | 0.004 | 0.209 | Plasminogen activator inhibitor antagonist | 0.102 0.01 DBMET01431 | ||
| 0.207 | 0.003 | 0.207 | Thromboxane synthase inhibitor | 0.111 0.005 DBMET01431 0.051 0.047 DBMET03515 | ||
| 0.258 | 0.058 | 0.379 | Calpain inhibitor | 0.246 0.069 DBMET01431 0.379 0.012 DBMET03515 | DBMET03515 | |
| 0.203 | 0.004 | 0.312 | Peroxisome proliferator-activated receptor delta antagonist | 0.312 0.003 DBMET01431 | DBMET01431 | |
| 0.201 | 0.003 | 0.201 | Prostaglandin agonist | 0.155 0.004 DBMET01431 | ||
| 0.209 | 0.011 | 0.253 | Mucolytic | 0.253 0.006 DBMET01431 0.169 0.023 DBMET03515 | DBMET01431 | |
| 0.238 | 0.041 | 0.39 | Anticoagulant | 0.22 0.046 DBMET01431 0.39 0.017 DBMET03515 | DBMET03515 | |
| 0.201 | 0.005 | 0.201 | Ornithine decarboxylase inhibitor | 0.14 0.014 DBMET01431 0.098 0.047 DBMET03515 | ||
| 0.199 | 0.005 | 0.285 | Glycine transporter 2 inhibitor | 0.062 0.024 DBMET01431 0.285 0.004 DBMET03515 | DBMET03515 | |
| 0.205 | 0.012 | 0.267 | Interleukin 8 antagonist | 0.267 0.005 DBMET01431 0.148 0.035 DBMET03515 | DBMET01431 | |
| 0.208 | 0.016 | 0.311 | Cyclooxygenase 3 inhibitor | 0.311 0.005 DBMET01431 0.244 0.009 DBMET03515 | DBMET01431 | |
| 0.204 | 0.012 | 0.306 | GABA C receptor antagonist | 0.306 0.004 DBMET01431 0.119 0.053 DBMET03515 | DBMET01431 | |
| 0.209 | 0.019 | 0.249 | Expectorant | 0.249 0.013 DBMET01431 0.136 0.041 DBMET03515 | DBMET01431 | |
| 0.223 | 0.033 | 0.381 | Thiol protease inhibitor | 0.166 0.057 DBMET01431 0.381 0.014 DBMET03515 | DBMET03515 | |
| 0.193 | 0.004 | 0.193 | Prostaglandin F2 alpha antagonist | 0.111 0.008 DBMET01431 | ||
| 0.243 | 0.054 | 0.255 | RNA-directed DNA polymerase inhibitor | 0.255 0.046 DBMET01431 | DBMET01431 | |
| 0.195 | 0.006 | 0.195 | Interferon agonist | 0.15 0.01 DBMET01431 0.104 0.025 DBMET03515 | ||
| 0.2 | 0.011 | 0.244 | Creatine kinase inhibitor | 0.244 0.006 DBMET01431 0.112 0.047 DBMET03515 | DBMET01431 | |
| 0.191 | 0.002 | 0.191 | G-protein-coupled receptor 120 agonist | 0.066 0.003 DBMET01431 | ||
| 0.196 | 0.009 | 0.196 | Keratolytic | 0.187 0.009 DBMET01431 0.089 0.038 DBMET03515 | ||
| 0.191 | 0.004 | 0.191 | Ca2+-transporting ATPase inhibitor | 0.189 0.005 DBMET01431 | ||
| 0.19 | 0.005 | 0.349 | CD45 antagonist | 0.102 0.009 DBMET01431 0.349 0.004 DBMET03515 | DBMET03515 | |
| 0.19 | 0.005 | 0.19 | Leukotriene synthesis inhibitor | 0.13 0.013 DBMET01431 | ||
| 0.187 | 0.004 | 0.187 | Thromboxane antagonist | 0.146 0.005 DBMET01431 | ||
| 0.23 | 0.048 | 0.277 | Nitric-oxide synthase stimulant | 0.277 0.018 DBMET01431 | DBMET01431 | |
| 0.203 | 0.022 | 0.304 | Cathepsin H inhibitor | 0.198 0.023 DBMET01431 0.304 0.009 DBMET03515 | DBMET03515 | |
| 0.189 | 0.007 | 0.193 | Interleukin 1 beta converting enzyme inhibitor | 0.169 0.011 DBMET01431 0.193 0.007 DBMET03515 | DBMET03515 | |
| 0.244 | 0.063 | 0.308 | Neuropeptide Y2 antagonist | 0.214 0.096 DBMET01431 0.308 0.015 DBMET03515 | DBMET03515 | |
| 0.24 | 0.061 | 0.244 | Anticonvulsant | 0.244 0.059 DBMET01431 0.22 0.07 DBMET03515 | DBMET01431 | |
| 0.188 | 0.01 | 0.273 | GABA C receptor rho-1 antagonist | 0.273 0.004 DBMET01431 0.122 0.038 DBMET03515 | DBMET01431 | |
| 0.203 | 0.025 | 0.203 | Alkylator | 0.146 0.048 DBMET01431 0.178 0.034 DBMET03515 | ||
| 0.223 | 0.045 | 0.227 | Dual specificity phosphatase inhibitor | 0.227 0.044 DBMET01431 | DBMET01431 | |
| 0.193 | 0.015 | 0.216 | NMDA receptor antagonist | 0.216 0.012 DBMET01431 0.164 0.02 DBMET03515 | DBMET01431 | |
| 0.18 | 0.004 | 0.18 | Leukotriene B4 antagonist | 0.124 0.007 DBMET01431 0.049 0.046 DBMET03515 | ||
| 0.18 | 0.004 | 0.18 | Leukotriene D4 antagonist | 0.069 0.008 DBMET01431 | ||
| 0.178 | 0.002 | 0.178 | ATP citrate lysase inhibitor | 0.077 0.004 DBMET01431 | ||
| 0.211 | 0.037 | 0.211 | NOS3 expression enhancer | 0.122 0.112 DBMET01431 | ||
| 0.188 | 0.015 | 0.188 | Carbonic anhydrase VI inhibitor | 0.164 0.018 DBMET01431 0.087 0.049 DBMET03515 | ||
| 0.225 | 0.052 | 0.225 | Hepatoprotectant | 0.204 0.063 DBMET01431 0.182 0.078 DBMET03515 | ||
| 0.201 | 0.028 | 0.24 | GABA C receptor rho-2 antagonist | 0.24 0.014 DBMET01431 | DBMET01431 | |
| 0.176 | 0.005 | 0.177 | Bile acid receptor antagonist | 0.177 0.005 DBMET01431 | DBMET01431 | |
| 0.19 | 0.019 | 0.286 | UDP-glucose 4-epimerase inhibitor | 0.286 0.011 DBMET01431 | DBMET01431 | |
| 0.174 | 0.004 | 0.174 | Leukotriene A4 hydrolase inhibitor | 0.039 0.026 DBMET01431 0.116 0.005 DBMET03515 | ||
| 0.173 | 0.004 | 0.173 | Thromboxane A2 antagonist | 0.134 0.004 DBMET01431 | ||
| 0.206 | 0.038 | 0.239 | Interleukin 6 antagonist | 0.239 0.025 DBMET01431 0.167 0.067 DBMET03515 | DBMET01431 | |
| 0.2 | 0.032 | 0.2 | Hemostatic | 0.183 0.041 DBMET01431 0.175 0.045 DBMET03515 | ||
| 0.301 | 0.135 | 0.305 | Antibacterial | 0.282 0.149 DBMET01431 0.305 0.132 DBMET03515 | DBMET03515 | |
| 0.184 | 0.018 | 0.184 | Mediator release inhibitor | 0.157 0.026 DBMET01431 0.124 0.044 DBMET03515 | ||
| 0.182 | 0.016 | 0.182 | Carbonic anhydrase XIII inhibitor | 0.136 0.025 DBMET01431 | ||
| 0.178 | 0.013 | 0.178 | Heat shock protein 70 antagonist | 0.169 0.018 DBMET01431 0.147 0.053 DBMET03515 | ||
| 0.173 | 0.008 | 0.186 | GP IIb/IIIa receptor antagonist | 0.182 0.008 DBMET01431 0.186 0.007 DBMET03515 | DBMET03515 | |
| 0.217 | 0.052 | 0.257 | Dual specificity phosphatase 3 inhibitor | 0.257 0.038 DBMET01431 | DBMET01431 | |
| 0.191 | 0.027 | 0.191 | CF transmembrane conductance regulator agonist | 0.166 0.052 DBMET01431 | ||
| 0.169 | 0.007 | 0.169 | Lanosterol 14 alpha demethylase inhibitor | 0.16 0.009 DBMET01431 | ||
| 0.206 | 0.045 | 0.206 | Antipruritic | 0.159 0.085 DBMET01431 0.145 0.101 DBMET03515 | ||
| 0.164 | 0.005 | 0.206 | NMDA receptor subunit 3B antagonist | 0.206 0.004 DBMET01431 0.123 0.008 DBMET03515 | DBMET01431 | |
| 0.166 | 0.009 | 0.191 | Glutathione S-transferase inhibitor | 0.161 0.01 DBMET01431 0.191 0.006 DBMET03515 | DBMET03515 | |
| 0.17 | 0.014 | 0.228 | NADH dehydrogenase inhibitor | 0.228 0.009 DBMET01431 0.083 0.069 DBMET03515 | DBMET01431 | |
| 0.159 | 0.003 | 0.159 | Free fatty acid receptor 1 agonist | 0.142 0.004 DBMET01431 | ||
| 0.16 | 0.006 | 0.16 | Purinergic P2X1 antagonist | 0.151 0.007 DBMET01431 | ||
| 0.166 | 0.011 | 0.166 | Anabolic | 0.152 0.017 DBMET01431 0.099 0.064 DBMET03515 | ||
| 0.159 | 0.005 | 0.159 | Peroxisome proliferator-activated receptor alpha agonist | 0.151 0.006 DBMET01431 | ||
| 0.157 | 0.003 | 0.157 | Prostaglandin E2 agonist | 0.119 0.004 DBMET01431 | ||
| 0.158 | 0.004 | 0.158 | Prostaglandin EP4 antagonist | 0.099 0.004 DBMET01431 | ||
| 0.182 | 0.028 | 0.182 | Farnesoid X receptor antagonist | 0.176 0.031 DBMET01431 | ||
| 0.188 | 0.035 | 0.241 | Cell wall synthesis inhibitor | 0.181 0.039 DBMET01431 0.241 0.018 DBMET03515 | DBMET03515 | |
| 0.18 | 0.03 | 0.194 | Adenylate cyclase inhibitor | 0.191 0.027 DBMET01431 0.194 0.027 DBMET03515 | DBMET03515 | |
| 0.16 | 0.011 | 0.16 | Acetylcholine release stimulant | 0.133 0.03 DBMET01431 | ||
| 0.178 | 0.029 | 0.183 | 5-Lipoxygenase inhibitor | 0.183 0.028 DBMET01431 | DBMET01431 | |
| 0.192 | 0.045 | 0.192 | Lipid peroxidase inhibitor | 0.127 0.087 DBMET01431 0.119 0.094 DBMET03515 | ||
| 0.151 | 0.004 | 0.151 | Sphingosine 1-phosphate receptor agonist | 0.096 0.006 DBMET01431 | ||
| 0.177 | 0.031 | 0.241 | Interleukin 4 antagonist | 0.241 0.014 DBMET01431 | DBMET01431 | |
| 0.156 | 0.01 | 0.156 | Glutamate (mGluR7) agonist | 0.133 0.02 DBMET01431 0.116 0.035 DBMET03515 | ||
| 0.262 | 0.116 | 0.374 | Thyroid hormone antagonist | 0.374 0.065 DBMET01431 | DBMET01431 | |
| 0.151 | 0.006 | 0.151 | Sphingosine 1-phosphate receptor antagonist | 0.101 0.021 DBMET01431 | ||
| 0.148 | 0.003 | 0.148 | AICAR transformylase inhibitor | 0.079 0.008 DBMET01431 0.142 0.003 DBMET03515 | ||
| 0.148 | 0.004 | 0.148 | Estrogen-related receptor beta agonist | 0.146 0.004 DBMET01431 0.098 0.027 DBMET03515 | ||
| 0.147 | 0.004 | 0.801 | Prostaglandin D2 antagonist | 0.801 0.002 DBMET01431 | DBMET01431 | |
| 0.146 | 0.004 | 0.146 | Glutamate (mGluR4) antagonist | 0.127 0.004 DBMET01431 0.118 0.004 DBMET03515 | ||
| 0.144 | 0.004 | 0.144 | Prostaglandin EP3 antagonist | 0.084 0.007 DBMET01431 | ||
| 0.154 | 0.014 | 0.154 | Macrophage migration inhibitory factor inhibitor | 0.124 0.024 DBMET01431 | ||
| 0.155 | 0.015 | 0.155 | Thioredoxin inhibitor | 0.082 0.077 DBMET01431 | ||
| 0.141 | 0.002 | 0.141 | Prostaglandin EP4 agonist | 0.132 0.003 DBMET01431 | ||
| 0.147 | 0.008 | 0.147 | Glycine receptor antagonist | 0.128 0.014 DBMET01431 0.078 0.061 DBMET03515 | ||
| 0.143 | 0.004 | 0.143 | Sphingosine 1-phosphate receptor 1 antagonist | 0.083 0.013 DBMET01431 0.052 0.049 DBMET03515 | ||
| 0.142 | 0.004 | 0.142 | Glutamate (mGluR group III) antagonist | 0.122 0.004 DBMET01431 0.077 0.008 DBMET03515 | ||
| 0.217 | 0.079 | 0.277 | Peptidyltransferase inhibitor | 0.243 0.056 DBMET01431 0.277 0.034 DBMET03515 | DBMET03515 | |
| 0.14 | 0.003 | 0.14 | Glucose-6-phosphate isomerase inhibitor | 0.119 0.004 DBMET01431 | ||
| 0.144 | 0.008 | 0.286 | NMDA 2A receptor antagonist | 0.098 0.014 DBMET01431 0.286 0.004 DBMET03515 | DBMET03515 | |
| 0.155 | 0.018 | 0.155 | Toll-Like receptor 4 antagonist | 0.121 0.042 DBMET01431 | ||
| 0.179 | 0.043 | 0.213 | Mannose-6-phosphate isomerase inhibitor | 0.213 0.024 DBMET01431 | DBMET01431 | |
| 0.145 | 0.01 | 0.176 | Acyl-CoA dehydrogenase inhibitor | 0.176 0.007 DBMET01431 0.081 0.022 DBMET03515 | DBMET01431 | |
| 0.163 | 0.029 | 0.181 | Nav1.4 sodium channel blocker | 0.159 0.03 DBMET01431 0.181 0.024 DBMET03515 | DBMET03515 | |
| 0.139 | 0.005 | 0.183 | NMDA receptor subunit 3A antagonist | 0.183 0.004 DBMET01431 0.082 0.011 DBMET03515 | DBMET01431 | |
| 0.139 | 0.006 | 0.139 | Macrophage elastase inhibitor | 0.106 0.009 DBMET01431 0.134 0.006 DBMET03515 | ||
| 0.147 | 0.013 | 0.147 | Interleukin 12 antagonist | 0.099 0.055 DBMET01431 0.105 0.046 DBMET03515 | ||
| 0.198 | 0.065 | 0.198 | P-glycoprotein inhibitor | 0.17 0.09 DBMET01431 | ||
| 0.181 | 0.048 | 0.196 | Hexokinase inhibitor | 0.196 0.038 DBMET01431 | DBMET01431 | |
| 0.144 | 0.011 | 0.144 | Vanilloid agonist | 0.132 0.014 DBMET01431 0.144 0.011 DBMET03515 | ||
| 0.136 | 0.003 | 0.136 | Leukotriene C antagonist | 0.108 0.004 DBMET01431 | ||
| 0.168 | 0.037 | 0.235 | Proteasome inhibitor | 0.151 0.046 DBMET01431 0.235 0.018 DBMET03515 | DBMET03515 | |
| 0.135 | 0.004 | 0.135 | Glutamate (mGluR7) antagonist | 0.129 0.004 DBMET01431 0.07 0.043 DBMET03515 | ||
| 0.134 | 0.003 | 0.134 | Glutamate (mGluR1a) agonist | 0.094 0.004 DBMET01431 0.05 0.005 DBMET03515 | ||
| 0.142 | 0.012 | 0.142 | Glutamate release inhibitor | 0.14 0.013 DBMET01431 | ||
| 0.134 | 0.004 | 0.134 | Prostacyclin antagonist | 0.115 0.004 DBMET01431 0.046 0.015 DBMET03515 | ||
| 0.133 | 0.004 | 0.133 | Sphingosine 1-phosphate receptor 1 agonist | 0.078 0.006 DBMET01431 | ||
| 0.153 | 0.025 | 0.153 | Gastric antisecretory | 0.109 0.054 DBMET01431 | ||
| 0.135 | 0.007 | 0.145 | Peroxisome proliferator-activated receptor gamma antagonist | 0.145 0.006 DBMET01431 | DBMET01431 | |
| 0.226 | 0.099 | 0.226 | Cardiotonic | 0.17 0.152 DBMET01431 | ||
| 0.129 | 0.004 | 0.129 | Kainate receptor 2 antagonist | 0.123 0.004 DBMET01431 0.11 0.004 DBMET03515 | ||
| 0.145 | 0.02 | 0.176 | Metalloproteinase-2 inhibitor | 0.108 0.035 DBMET01431 0.176 0.013 DBMET03515 | DBMET03515 | |
| 0.138 | 0.015 | 0.138 | CDC25A inhibitor | 0.129 0.017 DBMET01431 | ||
| 0.126 | 0.003 | 0.126 | Free fatty acid receptor 1 antagonist | 0.103 0.003 DBMET01431 | ||
| 0.133 | 0.009 | 0.133 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.082 0.024 DBMET01431 | ||
| 0.133 | 0.01 | 0.133 | Prostaglandin E2 antagonist | 0.095 0.016 DBMET01431 | ||
| 0.142 | 0.02 | 0.338 | ABCA1 expression enhancer | 0.338 0.005 DBMET01431 | DBMET01431 | |
| 0.126 | 0.004 | 0.151 | Retinoid X alpha receptor agonist | 0.151 0.003 DBMET01431 | DBMET01431 | |
| 0.133 | 0.011 | 0.133 | Carbonic anhydrase VB inhibitor | 0.108 0.014 DBMET01431 0.061 0.034 DBMET03515 | ||
| 0.139 | 0.017 | 0.171 | Carbonic anhydrase V inhibitor | 0.171 0.01 DBMET01431 0.087 0.032 DBMET03515 | DBMET01431 | |
| 0.135 | 0.012 | 0.321 | Carbonic anhydrase stimulant | 0.11 0.016 DBMET01431 0.321 0.004 DBMET03515 | DBMET03515 | |
| 0.126 | 0.004 | 0.126 | Lysophosphatidic acid 2 receptor antagonist | 0.117 0.004 DBMET01431 | ||
| 0.128 | 0.006 | 0.128 | Interferon inducer | 0.117 0.008 DBMET01431 0.084 0.021 DBMET03515 | ||
| 0.131 | 0.009 | 0.139 | NMDA 2C receptor antagonist | 0.134 0.008 DBMET01431 0.139 0.008 DBMET03515 | DBMET03515 | |
| 0.125 | 0.004 | 0.125 | Leukotriene B4 receptor 1 antagonist | 0.072 0.004 DBMET01431 | ||
| 0.14 | 0.018 | 0.14 | Histamine N-methyltransferase inhibitor | 0.125 0.026 DBMET01431 | ||
| 0.126 | 0.005 | 0.163 | Integrin alpha4 antagonist | 0.163 0.004 DBMET01431 0.16 0.004 DBMET03515 | DBMET01431 | |
| 0.242 | 0.122 | 0.419 | Immunomodulator | 0.27 0.1 DBMET01431 0.419 0.039 DBMET03515 | DBMET03515 | |
| 0.168 | 0.048 | 0.168 | Nav1.2 sodium channel blocker | 0.126 0.077 DBMET01431 0.141 0.063 DBMET03515 | ||
| 0.234 | 0.115 | 0.246 | Hypoxia-inducible factor 1 alpha inhibitor | 0.246 0.105 DBMET01431 | DBMET01431 | |
| 0.295 | 0.176 | 0.295 | Apoptosis agonist | |||
| 0.124 | 0.005 | 0.124 | Sphingosine 1-phosphate receptor 3 antagonist | 0.092 0.01 DBMET01431 0.06 0.037 DBMET03515 | ||
| 0.143 | 0.026 | 0.189 | Uric acid excretion stimulant | 0.189 0.014 DBMET01431 | DBMET01431 | |
| 0.124 | 0.008 | 0.146 | NMDA receptor glycine site agonist | 0.146 0.005 DBMET01431 0.124 0.008 DBMET03515 | DBMET01431 | |
| 0.131 | 0.015 | 0.157 | Carbonic anhydrase VA inhibitor | 0.157 0.009 DBMET01431 0.091 0.029 DBMET03515 | DBMET01431 | |
| 0.127 | 0.012 | 0.127 | Caspase 7 inhibitor | 0.096 0.034 DBMET01431 0.077 0.068 DBMET03515 | ||
| 0.121 | 0.006 | 0.121 | Vanilloid 4 agonist | 0.094 0.022 DBMET01431 | ||
| 0.142 | 0.028 | 0.142 | Sphingomyelinase inhibitor | 0.134 0.032 DBMET01431 0.094 0.066 DBMET03515 | ||
| 0.132 | 0.018 | 0.31 | Hematopoietic | 0.095 0.041 DBMET01431 0.31 0.005 DBMET03515 | DBMET03515 | |
| 0.155 | 0.042 | 0.155 | Antibacterial (Helicobacter pylori) | 0.155 0.042 DBMET01431 | ||
| 0.116 | 0.004 | 0.121 | Lysophosphatidic acid 3 receptor antagonist | 0.121 0.004 DBMET01431 0.105 0.004 DBMET03515 | DBMET01431 | |
| 0.142 | 0.033 | 0.164 | AMP-activated protein kinase stimulant | 0.164 0.02 DBMET01431 | DBMET01431 | |
| 0.154 | 0.046 | 0.154 | Pregnane X receptor agonist | 0.144 0.064 DBMET01431 | ||
| 0.255 | 0.146 | 0.432 | Calpain 2 inhibitor | 0.26 0.142 DBMET01431 0.432 0.046 DBMET03515 | DBMET03515 | |
| 0.137 | 0.029 | 0.137 | Electron transport complex I inhibitor | |||
| 0.11 | 0.003 | 0.11 | Glutamate (mGluR8) agonist | 0.095 0.003 DBMET01431 0.072 0.005 DBMET03515 | ||
| 0.123 | 0.016 | 0.158 | Neutrophil collagenase inhibitor | 0.095 0.024 DBMET01431 0.158 0.011 DBMET03515 | DBMET03515 | |
| 0.11 | 0.004 | 0.11 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.066 0.005 DBMET01431 0.047 0.011 DBMET03515 | ||
| 0.145 | 0.039 | 0.191 | Falcipain 3 inhibitor | 0.145 0.039 DBMET01431 0.191 0.02 DBMET03515 | DBMET03515 | |
| 0.108 | 0.003 | 0.108 | Leukotriene C4 antagonist | 0.082 0.004 DBMET01431 | ||
| 0.191 | 0.086 | 0.191 | Pyruvate kinase inhibitor | 0.18 0.093 DBMET01431 | ||
| 0.109 | 0.005 | 0.12 | Peroxisome proliferator-activated receptor delta agonist | 0.12 0.005 DBMET01431 | DBMET01431 | |
| 0.159 | 0.055 | 0.296 | Histone deacetylase SIRT1 inhibitor | 0.296 0.008 DBMET03515 | DBMET03515 | |
| 0.108 | 0.004 | 0.125 | Retinoid X receptor agonist | 0.125 0.003 DBMET01431 | DBMET01431 | |
| 0.255 | 0.152 | 0.416 | Antiobesity | 0.416 0.06 DBMET01431 | DBMET01431 | |
| 0.119 | 0.016 | 0.189 | Ribonucleoside-diphosphate reductase inhibitor | 0.069 0.029 DBMET01431 0.189 0.007 DBMET03515 | DBMET03515 | |
| 0.148 | 0.045 | 0.238 | Histone deacetylase class III inhibitor | 0.238 0.011 DBMET03515 | DBMET03515 | |
| 0.155 | 0.052 | 0.189 | M17 leucyl aminopeptidase inhibitor | 0.189 0.037 DBMET01431 | DBMET01431 | |
| 0.11 | 0.009 | 0.11 | 5-Alpha-reductase inhibitor | 0.091 0.011 DBMET01431 | ||
| 0.127 | 0.026 | 0.127 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.123 0.028 DBMET01431 | ||
| 0.105 | 0.004 | 0.105 | GABA uptake inhibitor | 0.087 0.004 DBMET01431 | ||
| 0.106 | 0.005 | 0.106 | Mannosidase inhibitor | 0.088 0.007 DBMET01431 0.072 0.011 DBMET03515 | ||
| 0.13 | 0.03 | 0.13 | Calcium antagonist | 0.105 0.045 DBMET01431 | ||
| 0.107 | 0.007 | 0.254 | Kainate receptor antagonist | 0.165 0.004 DBMET01431 0.254 0.003 DBMET03515 | DBMET03515 | |
| 0.104 | 0.005 | 0.227 | AMPA 4 receptor antagonist | 0.17 0.004 DBMET01431 0.227 0.003 DBMET03515 | DBMET03515 | |
| 0.136 | 0.037 | 0.166 | Carbonic anhydrase XV inhibitor | 0.166 0.026 DBMET01431 0.094 0.075 DBMET03515 | DBMET01431 | |
| 0.139 | 0.04 | 0.156 | Chelator | 0.115 0.059 DBMET01431 0.156 0.033 DBMET03515 | DBMET03515 | |
| 0.17 | 0.071 | 0.25 | ATPase inhibitor | 0.25 0.014 DBMET01431 | DBMET01431 | |
| 0.11 | 0.011 | 0.11 | Caspase 9 inhibitor | 0.082 0.022 DBMET01431 0.108 0.012 DBMET03515 | ||
| 0.104 | 0.005 | 0.114 | MDM2 inhibitor | 0.114 0.004 DBMET01431 0.071 0.036 DBMET03515 | DBMET01431 | |
| 0.116 | 0.017 | 0.187 | Ribonucleotide reductase inhibitor | 0.071 0.031 DBMET01431 0.187 0.008 DBMET03515 | DBMET03515 | |
| 0.104 | 0.006 | 0.104 | Sphingosine 1-phosphate receptor 3 agonist | 0.052 0.015 DBMET01431 | ||
| 0.112 | 0.015 | 0.123 | Antimetabolite | 0.066 0.023 DBMET01431 0.123 0.014 DBMET03515 | DBMET03515 | |
| 0.141 | 0.043 | 0.158 | Microtubule formation inhibitor | 0.158 0.034 DBMET01431 | DBMET01431 | |
| 0.102 | 0.005 | 0.102 | Dihydropteroate synthase inhibitor | 0.055 0.014 DBMET01431 | ||
| 0.112 | 0.014 | 0.266 | Ornithine carbamoyltransferase inhibitor | 0.133 0.011 DBMET01431 0.266 0.005 DBMET03515 | DBMET03515 | |
| 0.1 | 0.003 | 0.1 | Prostaglandin EP2 agonist | 0.062 0.004 DBMET01431 | ||
| 0.102 | 0.005 | 0.102 | Nicotinic acid receptor agonist | 0.088 0.005 DBMET01431 | ||
| 0.107 | 0.011 | 0.107 | Phospholipase D inhibitor | 0.1 0.014 DBMET01431 0.069 0.055 DBMET03515 | ||
| 0.119 | 0.022 | 0.189 | Selectin antagonist | 0.16 0.016 DBMET01431 0.189 0.012 DBMET03515 | DBMET03515 | |
| 0.11 | 0.013 | 0.11 | Maillard reaction inhibitor | 0.097 0.018 DBMET01431 0.071 0.029 DBMET03515 | ||
| 0.103 | 0.007 | 0.103 | Sphingosine kinase inhibitor | 0.069 0.026 DBMET01431 0.059 0.04 DBMET03515 | ||
| 0.113 | 0.018 | 0.113 | Amidase inhibitor | 0.095 0.027 DBMET01431 | ||
| 0.228 | 0.133 | 0.326 | Thyroid hormone beta antagonist | 0.326 0.077 DBMET01431 | DBMET01431 | |
| 0.104 | 0.008 | 0.104 | Oleamide hydrolase inhibitor | 0.055 0.023 DBMET01431 | ||
| 0.134 | 0.039 | 0.148 | Transcription factor STAT6 inhibitor | 0.124 0.053 DBMET01431 0.148 0.024 DBMET03515 | DBMET03515 | |
| 0.098 | 0.005 | 0.108 | Peroxisome proliferator-activated receptor alpha antagonist | 0.108 0.004 DBMET01431 | DBMET01431 | |
| 0.099 | 0.006 | 0.127 | VLA-4 antagonist | 0.123 0.005 DBMET01431 0.127 0.005 DBMET03515 | DBMET03515 | |
| 0.113 | 0.021 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | 0.134 0.009 DBMET01431 | DBMET01431 | |
| 0.126 | 0.034 | 0.179 | Nitric-oxide synthase inhibitor | 0.101 0.058 DBMET01431 0.179 0.014 DBMET03515 | DBMET03515 | |
| 0.213 | 0.121 | 0.439 | Transcription factor STAT inhibitor | 0.191 0.151 DBMET01431 0.439 0.013 DBMET03515 | DBMET03515 | |
| 0.116 | 0.025 | 0.152 | NMDA 2 receptor antagonist | 0.099 0.032 DBMET01431 0.152 0.016 DBMET03515 | DBMET03515 | |
| 0.211 | 0.121 | 0.417 | Transcription factor STAT3 inhibitor | 0.199 0.134 DBMET01431 0.417 0.016 DBMET03515 | DBMET03515 | |
| 0.095 | 0.005 | 0.117 | Urate transporter 1 inhibitor | 0.117 0.005 DBMET01431 | DBMET01431 | |
| 0.093 | 0.004 | 0.093 | Lysine carboxypeptidase inhibitor | 0.059 0.006 DBMET01431 0.085 0.004 DBMET03515 | ||
| 0.126 | 0.038 | 0.233 | Potassium channel (Ca-activated) activator | 0.233 0.009 DBMET01431 0.1 0.055 DBMET03515 | DBMET01431 | |
| 0.105 | 0.017 | 0.105 | CC chemokine 5 receptor agonist | 0.091 0.034 DBMET01431 0.088 0.041 DBMET03515 | ||
| 0.115 | 0.027 | 0.156 | Inducible nitric-oxide synthase inhibitor | 0.098 0.039 DBMET01431 0.156 0.015 DBMET03515 | DBMET03515 | |
| 0.092 | 0.004 | 0.092 | Arginase inhibitor | 0.068 0.008 DBMET01431 0.075 0.006 DBMET03515 | ||
| 0.104 | 0.017 | 0.298 | Aldose reductase inhibitor | 0.298 0.004 DBMET01431 | DBMET01431 | |
| 0.127 | 0.041 | 0.127 | Bronchodilator | 0.105 0.058 DBMET01431 | ||
| 0.103 | 0.018 | 0.103 | Elastase 1 inhibitor | 0.101 0.019 DBMET01431 0.067 0.051 DBMET03515 | ||
| 0.113 | 0.029 | 0.117 | Adrenaline agonist | 0.117 0.027 DBMET01431 0.078 0.061 DBMET03515 | DBMET01431 | |
| 0.091 | 0.007 | 0.091 | Squalene synthetase inhibitor | 0.069 0.01 DBMET01431 | ||
| 0.121 | 0.038 | 0.153 | Factor V inhibitor | 0.098 0.074 DBMET01431 0.153 0.017 DBMET03515 | DBMET03515 | |
| 0.088 | 0.005 | 0.111 | Vitronectin receptor antagonist | 0.111 0.004 DBMET01431 0.054 0.006 DBMET03515 | DBMET01431 | |
| 0.084 | 0.002 | 0.084 | Prostaglandin H2 antagonist | 0.059 0.003 DBMET01431 | ||
| 0.086 | 0.005 | 0.086 | Membrane dipeptidase inhibitor | 0.069 0.007 DBMET01431 0.086 0.005 DBMET03515 | ||
| 0.084 | 0.002 | 0.084 | Prostaglandin F2 alpha agonist | 0.057 0.004 DBMET01431 | ||
| 0.165 | 0.084 | 0.165 | Nitric oxide antagonist | 0.161 0.087 DBMET01431 | ||
| 0.09 | 0.01 | 0.12 | Diacylglycerol O-acyltransferase inhibitor | 0.12 0.005 DBMET01431 | DBMET01431 | |
| 0.084 | 0.004 | 0.119 | Kainate receptor agonist | 0.119 0.002 DBMET01431 0.071 0.004 DBMET03515 | DBMET01431 | |
| 0.09 | 0.01 | 0.09 | Sphingosine kinase 2 inhibitor | 0.07 0.021 DBMET01431 | ||
| 0.11 | 0.03 | 0.14 | Chymotrypsin inhibitor | 0.105 0.033 DBMET01431 0.14 0.019 DBMET03515 | DBMET03515 | |
| 0.088 | 0.008 | 0.156 | DNA helicase inhibitor | 0.156 0.003 DBMET01431 0.081 0.01 DBMET03515 | DBMET01431 | |
| 0.083 | 0.005 | 0.083 | Dopamine beta hydroxylase inhibitor | 0.077 0.005 DBMET01431 | ||
| 0.096 | 0.017 | 0.185 | Protease 3C (Human rhinovirus) inhibitor | 0.091 0.02 DBMET01431 0.185 0.005 DBMET03515 | DBMET03515 | |
| 0.103 | 0.025 | 0.138 | Matrix metalloproteinase inhibitor | 0.079 0.038 DBMET01431 0.138 0.015 DBMET03515 | DBMET03515 | |
| 0.187 | 0.109 | 0.271 | Antiamyloidogenic | 0.177 0.117 DBMET01431 0.271 0.062 DBMET03515 | DBMET03515 | |
| 0.086 | 0.009 | 0.086 | Prolyl endopeptidase inhibitor | 0.066 0.019 DBMET01431 0.064 0.02 DBMET03515 | ||
| 0.109 | 0.032 | 0.124 | Transcription factor NF kappa B stimulant | 0.124 0.023 DBMET03515 | DBMET03515 | |
| 0.083 | 0.007 | 0.105 | Thymidylate synthase inhibitor | 0.075 0.009 DBMET01431 0.105 0.004 DBMET03515 | DBMET03515 | |
| 0.099 | 0.023 | 0.131 | Glucagon-like peptide 1 agonist | 0.075 0.038 DBMET01431 0.131 0.012 DBMET03515 | DBMET03515 | |
| 0.087 | 0.012 | 0.087 | Glutamate (mGluR group III) agonist | 0.069 0.015 DBMET01431 | ||
| 0.103 | 0.029 | 0.103 | Na+ K+ transporting ATPase inhibitor | 0.097 0.035 DBMET01431 | ||
| 0.083 | 0.009 | 0.083 | Adenosine deaminase inhibitor | 0.076 0.011 DBMET01431 0.063 0.018 DBMET03515 | ||
| 0.08 | 0.006 | 0.08 | Pregnane X receptor antagonist | 0.078 0.007 DBMET01431 | ||
| 0.084 | 0.011 | 0.084 | Epithelial sodium channel blocker | 0.063 0.024 DBMET01431 0.075 0.015 DBMET03515 | ||
| 0.078 | 0.005 | 0.078 | Geranyltranstransferase inhibitor | 0.072 0.007 DBMET01431 | ||
| 0.11 | 0.036 | 0.11 | Phosphodiesterase 6D inhibitor | 0.092 0.071 DBMET01431 | ||
| 0.083 | 0.01 | 0.094 | Alpha-mannosidase inhibitor | 0.094 0.007 DBMET01431 0.082 0.01 DBMET03515 | DBMET01431 | |
| 0.079 | 0.007 | 0.098 | Heparanase inhibitor | 0.098 0.004 DBMET01431 0.062 0.02 DBMET03515 | DBMET01431 | |
| 0.076 | 0.004 | 0.076 | Glutamate (mGluR8) antagonist | 0.064 0.005 DBMET01431 0.053 0.007 DBMET03515 | ||
| 0.148 | 0.076 | 0.149 | Acetylcholine M1 receptor antagonist | 0.149 0.076 DBMET01431 | DBMET01431 | |
| 0.076 | 0.004 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 DBMET01431 | ||
| 0.074 | 0.002 | 0.074 | Thromboxane agonist | 0.024 0.003 DBMET01431 | ||
| 0.077 | 0.005 | 0.077 | Glucagon receptor antagonist | 0.034 0.017 DBMET01431 | ||
| 0.075 | 0.004 | 0.075 | Prostaglandin D2 agonist | 0.061 0.005 DBMET01431 | ||
| 0.217 | 0.146 | 0.217 | Caspase 3 stimulant | |||
| 0.136 | 0.065 | 0.195 | NADPH oxidase inhibitor | 0.195 0.036 DBMET01431 | DBMET01431 | |
| 0.076 | 0.005 | 0.076 | Dihydrofolate reductase inhibitor | 0.049 0.019 DBMET01431 0.049 0.02 DBMET03515 | ||
| 0.088 | 0.017 | 0.124 | Matrix metalloproteinase (membrane-type) inhibitor | 0.067 0.026 DBMET01431 0.124 0.011 DBMET03515 | DBMET03515 | |
| 0.128 | 0.058 | 0.128 | DNA repair enzyme inhibitor | 0.126 0.061 DBMET01431 0.115 0.082 DBMET03515 | ||
| 0.101 | 0.032 | 0.141 | Metalloproteinase-9 inhibitor | 0.089 0.038 DBMET01431 0.141 0.018 DBMET03515 | DBMET03515 | |
| 0.077 | 0.007 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.073 0.009 DBMET01431 0.074 0.009 DBMET03515 | ||
| 0.074 | 0.004 | 0.074 | Kynurenine 3 monooxygenase inhibitor | 0.073 0.004 DBMET01431 | ||
| 0.09 | 0.021 | 0.09 | Beta adrenoreceptor antagonist | 0.084 0.024 DBMET01431 0.064 0.048 DBMET03515 | ||
| 0.072 | 0.003 | 0.076 | Thyroid hormone agonist | 0.076 0.003 DBMET01431 0.026 0.018 DBMET03515 | DBMET01431 | |
| 0.072 | 0.003 | 0.072 | Lysophosphatidic acid 1 receptor antagonist | 0.06 0.003 DBMET01431 | ||
| 0.073 | 0.004 | 0.073 | Heme oxygenase inhibitor | 0.056 0.008 DBMET01431 | ||
| 0.152 | 0.084 | 0.152 | Sigma receptor agonist | |||
| 0.075 | 0.007 | 0.093 | Dopamine D5 agonist | 0.093 0.005 DBMET01431 | DBMET01431 | |
| 0.101 | 0.033 | 0.101 | Myeloperoxidase inhibitor | 0.081 0.065 DBMET01431 | ||
| 0.086 | 0.018 | 0.121 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.121 0.011 DBMET01431 | DBMET01431 | |
| 0.082 | 0.015 | 0.087 | Metalloproteinase-3 inhibitor | 0.049 0.034 DBMET01431 0.087 0.014 DBMET03515 | DBMET03515 | |
| 0.07 | 0.003 | 0.07 | Lysophosphatidic acid receptor 1 agonist | 0.066 0.003 DBMET01431 0.048 0.004 DBMET03515 | ||
| 0.096 | 0.029 | 0.096 | Lipase inhibitor | |||
| 0.076 | 0.011 | 0.076 | Ryanodine receptor antagonist | 0.072 0.015 DBMET01431 | ||
| 0.177 | 0.113 | 0.206 | 5 Hydroxytryptamine 3E antagonist | 0.206 0.052 DBMET01431 | DBMET01431 | |
| 0.1 | 0.036 | 0.1 | CYP2A6 inhibitor | 0.089 0.042 DBMET01431 | ||
| 0.068 | 0.004 | 0.068 | Prostacyclin agonist | 0.021 0.008 DBMET01431 | ||
| 0.084 | 0.021 | 0.084 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 DBMET01431 | ||
| 0.097 | 0.033 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.116 0.016 DBMET01431 | DBMET01431 | |
| 0.08 | 0.018 | 0.08 | Beta 1 adrenoreceptor antagonist | 0.077 0.02 DBMET01431 | ||
| 0.072 | 0.011 | 0.072 | Fructose-1,6-bisphosphatase inhibitor | 0.062 0.016 DBMET01431 | ||
| 0.101 | 0.04 | 0.131 | Interleukin 5 antagonist | 0.131 0.017 DBMET01431 | DBMET01431 | |
| 0.076 | 0.015 | 0.102 | Angiotensin-converting enzyme inhibitor | 0.065 0.024 DBMET01431 0.102 0.008 DBMET03515 | DBMET03515 | |
| 0.083 | 0.023 | 0.083 | Collagenase 3 inhibitor | 0.075 0.028 DBMET01431 0.071 0.031 DBMET03515 | ||
| 0.07 | 0.01 | 0.07 | G protein-coupled receptor agonist | 0.035 0.029 DBMET01431 | ||
| 0.064 | 0.005 | 0.092 | Liver X receptor beta antagonist | 0.092 0.004 DBMET01431 | DBMET01431 | |
| 0.064 | 0.004 | 0.064 | Integrin alphaVbeta3 antagonist | 0.038 0.005 DBMET01431 0.037 0.006 DBMET03515 | ||
| 0.092 | 0.033 | 0.092 | Estrogen receptor alpha antagonist | 0.08 0.049 DBMET01431 | ||
| 0.063 | 0.005 | 0.072 | Retinoid X receptor antagonist | 0.072 0.004 DBMET01431 | DBMET01431 | |
| 0.073 | 0.015 | 0.073 | Beta 2 adrenoreceptor antagonist | 0.067 0.018 DBMET01431 0.046 0.042 DBMET03515 | ||
| 0.081 | 0.023 | 0.094 | Exportin-1 inhibitor | 0.094 0.012 DBMET01431 | DBMET01431 | |
| 0.063 | 0.005 | 0.179 | AMPA 3 receptor antagonist | 0.105 0.004 DBMET01431 0.179 0.003 DBMET03515 | DBMET03515 | |
| 0.061 | 0.004 | 0.061 | Glutamate (mGluR3) agonist | 0.054 0.004 DBMET01431 0.048 0.005 DBMET03515 | ||
| 0.059 | 0.002 | 0.059 | Thromboxane A2 agonist | 0.03 0.003 DBMET01431 | ||
| 0.09 | 0.033 | 0.09 | Epoxide hydrolase inhibitor | 0.076 0.046 DBMET01431 0.068 0.057 DBMET03515 | ||
| 0.062 | 0.005 | 0.062 | Angiotensin AT1 receptor antagonist | 0.061 0.005 DBMET01431 | ||
| 0.061 | 0.004 | 0.093 | Glutamate (mGluR1) agonist | 0.093 0.004 DBMET01431 0.038 0.006 DBMET03515 | DBMET01431 | |
| 0.075 | 0.018 | 0.208 | Bombesin 2 receptor antagonist | 0.089 0.015 DBMET01431 0.208 0.007 DBMET03515 | DBMET03515 | |
| 0.072 | 0.016 | 0.076 | Beta 2 adrenoreceptor agonist | 0.069 0.021 DBMET01431 0.076 0.012 DBMET03515 | DBMET03515 | |
| 0.061 | 0.005 | 0.077 | VCAM-1 antagonist | 0.05 0.009 DBMET01431 0.077 0.005 DBMET03515 | DBMET03515 | |
| 0.071 | 0.015 | 0.071 | Purinergic P2Y antagonist | 0.04 0.036 DBMET01431 | ||
| 0.061 | 0.005 | 0.077 | VCAM antagonist | 0.05 0.009 DBMET01431 0.077 0.005 DBMET03515 | DBMET03515 | |
| 0.063 | 0.008 | 0.063 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.032 DBMET03515 | ||
| 0.059 | 0.004 | 0.075 | Tryptophan 5 hydroxylase inhibitor | 0.075 0.003 DBMET01431 0.051 0.005 DBMET03515 | DBMET01431 | |
| 0.11 | 0.056 | 0.187 | Protease inhibitor | 0.097 0.068 DBMET01431 0.187 0.017 DBMET03515 | DBMET03515 | |
| 0.057 | 0.003 | 0.057 | Calcium-independent phospholipase A2 inhibitor | 0.038 0.014 DBMET01431 0.034 0.024 DBMET03515 | ||
| 0.092 | 0.038 | 0.092 | Nicotinic alpha4beta2 receptor antagonist | 0.068 0.064 DBMET01431 | ||
| 0.062 | 0.009 | 0.062 | Sphingosine kinase 1 inhibitor | 0.044 0.024 DBMET01431 | ||
| 0.057 | 0.004 | 0.057 | Leukotriene B4 receptor 2 antagonist | 0.052 0.004 DBMET01431 | ||
| 0.063 | 0.01 | 0.066 | GABA B receptor antagonist | 0.066 0.01 DBMET01431 | DBMET01431 | |
| 0.056 | 0.003 | 0.056 | Nicotinic acid receptor 2 antagonist | 0.052 0.004 DBMET01431 | ||
| 0.08 | 0.028 | 0.08 | CDC25B inhibitor | 0.071 0.037 DBMET01431 | ||
| 0.057 | 0.005 | 0.057 | Angiotensin II receptor antagonist | 0.053 0.005 DBMET01431 | ||
| 0.061 | 0.009 | 0.224 | AMPA 1 receptor antagonist | 0.108 0.005 DBMET01431 0.224 0.004 DBMET03515 | DBMET03515 | |
| 0.056 | 0.005 | 0.056 | Methionyl aminopeptidase 1 inhibitor | 0.044 0.009 DBMET01431 0.044 0.009 DBMET03515 | ||
| 0.058 | 0.008 | 0.074 | Integrin alpha2 antagonist | 0.074 0.005 DBMET01431 0.062 0.007 DBMET03515 | DBMET01431 | |
| 0.055 | 0.005 | 0.058 | Integrin alpha1beta1 antagonist | 0.048 0.009 DBMET01431 0.058 0.005 DBMET03515 | DBMET03515 | |
| 0.055 | 0.005 | 0.148 | Kainate receptor 1 antagonist | 0.087 0.004 DBMET01431 0.148 0.003 DBMET03515 | DBMET03515 | |
| 0.071 | 0.021 | 0.071 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.07 0.022 DBMET01431 | ||
| 0.089 | 0.039 | 0.089 | T cell inhibitor | 0.078 0.075 DBMET01431 | ||
| 0.07 | 0.02 | 0.07 | Carbonic anhydrase XIV inhibitor | 0.06 0.025 DBMET01431 | ||
| 0.076 | 0.027 | 0.133 | Aminopeptidase microsomal inhibitor | 0.096 0.019 DBMET01431 0.133 0.011 DBMET03515 | DBMET03515 | |
| 0.105 | 0.056 | 0.125 | Xanthine oxidase inhibitor | 0.125 0.045 DBMET01431 | DBMET01431 | |
| 0.054 | 0.006 | 0.054 | Vanilloid 3 antagonist | 0.05 0.009 DBMET01431 | ||
| 0.052 | 0.005 | 0.063 | Retinoid X alpha receptor antagonist | 0.063 0.004 DBMET01431 | DBMET01431 | |
| 0.064 | 0.017 | 0.092 | Cholecystokinin antagonist | 0.047 0.026 DBMET01431 0.092 0.009 DBMET03515 | DBMET03515 | |
| 0.05 | 0.003 | 0.05 | Vanilloid 2 agonist | 0.041 0.004 DBMET01431 | ||
| 0.059 | 0.012 | 0.065 | Integrin alpha5beta1 antagonist | 0.063 0.01 DBMET01431 0.065 0.01 DBMET03515 | DBMET03515 | |
| 0.051 | 0.004 | 0.051 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.013 0.012 DBMET01431 0.043 0.004 DBMET03515 | ||
| 0.053 | 0.007 | 0.068 | Carnitine palmitoyltransferase inhibitor | 0.068 0.004 DBMET01431 | DBMET01431 | |
| 0.106 | 0.059 | 0.106 | Nav1.1 sodium channel blocker | |||
| 0.059 | 0.013 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 DBMET01431 | DBMET01431 | |
| 0.052 | 0.007 | 0.055 | Uridine phosphorylase inhibitor | 0.055 0.007 DBMET01431 | DBMET01431 | |
| 0.046 | 0.002 | 0.046 | Glutamate (mGluR6) agonist | 0.027 0.003 DBMET01431 0.017 0.005 DBMET03515 | ||
| 0.113 | 0.069 | 0.113 | Estrogen antagonist | |||
| 0.062 | 0.019 | 0.201 | Toll-Like receptor 2 agonist | 0.045 0.026 DBMET01431 0.201 0.007 DBMET03515 | DBMET03515 | |
| 0.09 | 0.048 | 0.09 | Histamine H1 receptor antagonist | 0.081 0.056 DBMET01431 | ||
| 0.088 | 0.046 | 0.097 | Glutamate receptor agonist | 0.097 0.039 DBMET01431 | DBMET01431 | |
| 0.058 | 0.016 | 0.058 | Histone deacetylase 7 inhibitor | 0.038 0.024 DBMET03515 | ||
| 0.049 | 0.007 | 0.049 | Carboxypeptidase B inhibitor | 0.041 0.012 DBMET01431 0.048 0.007 DBMET03515 | ||
| 0.047 | 0.005 | 0.11 | Retinoid X beta receptor agonist | 0.11 0.003 DBMET01431 | DBMET01431 | |
| 0.056 | 0.015 | 0.126 | Liver X receptor alpha agonist | 0.126 0.004 DBMET01431 | DBMET01431 | |
| 0.047 | 0.006 | 0.102 | Retinoid X gamma receptor agonist | 0.102 0.004 DBMET01431 | DBMET01431 | |
| 0.082 | 0.041 | 0.088 | MAP kinase kinase 7 inhibitor | 0.088 0.028 DBMET01431 | DBMET01431 | |
| 0.054 | 0.013 | 0.054 | Phosphoglycerate kinase inhibitor | 0.048 0.015 DBMET01431 | ||
| 0.113 | 0.072 | 0.113 | Anesthetic local | 0.113 0.072 DBMET01431 | ||
| 0.08 | 0.039 | 0.091 | Prostaglandin-E synthase inhibitor | 0.091 0.032 DBMET01431 | DBMET01431 | |
| 0.046 | 0.005 | 0.077 | Integrin alpha4beta7 antagonist | 0.077 0.004 DBMET01431 0.05 0.005 DBMET03515 | DBMET01431 | |
| 0.045 | 0.004 | 0.264 | Thyroid hormone alpha antagonist | 0.264 0.002 DBMET01431 | DBMET01431 | |
| 0.049 | 0.008 | 0.065 | Carnitine palmitoyltransferase 1 inhibitor | 0.065 0.004 DBMET01431 | DBMET01431 | |
| 0.14 | 0.1 | 0.14 | Mcl-1 antagonist | |||
| 0.055 | 0.016 | 0.055 | Thymidine kinase inhibitor | 0.049 0.02 DBMET01431 | ||
| 0.061 | 0.021 | 0.138 | Complement C3a chemotactic receptor antagonist | 0.058 0.023 DBMET01431 0.138 0.004 DBMET03515 | DBMET03515 | |
| 0.106 | 0.067 | 0.106 | Protein kinase C gamma inhibitor | |||
| 0.047 | 0.009 | 0.047 | HMG CoA reductase inhibitor | 0.038 0.017 DBMET01431 | ||
| 0.057 | 0.019 | 0.058 | Leukocyte elastase inhibitor | 0.058 0.019 DBMET01431 0.045 0.027 DBMET03515 | DBMET01431 | |
| 0.062 | 0.024 | 0.157 | Endothelin-converting enzyme inhibitor | 0.044 0.035 DBMET01431 0.157 0.008 DBMET03515 | DBMET03515 | |
| 0.078 | 0.04 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.021 DBMET01431 | DBMET01431 | |
| 0.044 | 0.007 | 0.045 | Integrin beta3 antagonist | 0.045 0.007 DBMET01431 0.035 0.008 DBMET03515 | DBMET01431 | |
| 0.041 | 0.004 | 0.041 | Ileal bile acid transport inhibitor | 0.018 0.01 DBMET01431 0.028 0.005 DBMET03515 | ||
| 0.041 | 0.004 | 0.074 | Aminopeptidase A inhibitor | 0.041 0.004 DBMET01431 0.074 0.002 DBMET03515 | DBMET03515 | |
| 0.044 | 0.007 | 0.082 | Integrin beta7 antagonist | 0.082 0.005 DBMET01431 0.067 0.005 DBMET03515 | DBMET01431 | |
| 0.07 | 0.033 | 0.07 | Nitric oxide donor | 0.064 0.042 DBMET03515 | ||
| 0.04 | 0.003 | 0.04 | Carbonic anhydrase X inhibitor | 0.029 0.004 DBMET01431 0.019 0.009 DBMET03515 | ||
| 0.04 | 0.003 | 0.04 | Carbonic anhydrase VIII inhibitor | 0.029 0.004 DBMET01431 0.019 0.009 DBMET03515 | ||
| 0.051 | 0.015 | 0.175 | Cholecystokinin B agonist | 0.175 0.004 DBMET03515 | DBMET03515 | |
| 0.106 | 0.07 | 0.122 | GABA receptor agonist | 0.122 0.055 DBMET01431 | DBMET01431 | |
| 0.041 | 0.005 | 0.041 | Integrin alphaVbeta1 antagonist | 0.032 0.005 DBMET01431 0.026 0.007 DBMET03515 | ||
| 0.105 | 0.069 | 0.108 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 DBMET01431 | DBMET01431 | |
| 0.061 | 0.025 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | 0.058 0.029 DBMET01431 | ||
| 0.059 | 0.024 | 0.059 | Vanilloid 2 antagonist | 0.05 0.041 DBMET01431 0.052 0.036 DBMET03515 | ||
| 0.061 | 0.027 | 0.08 | Dihydroorotate oxidase inhibitor | 0.08 0.011 DBMET01431 | DBMET01431 | |
| 0.038 | 0.003 | 0.038 | Retinoid X beta receptor antagonist | 0.035 0.004 DBMET01431 | ||
| 0.049 | 0.015 | 0.051 | Farnesoid X receptor agonist | 0.051 0.014 DBMET01431 | DBMET01431 | |
| 0.16 | 0.126 | 0.16 | Histone acetyltransferase inhibitor | |||
| 0.043 | 0.009 | 0.049 | Neutral endopeptidase inhibitor | 0.027 0.013 DBMET01431 0.049 0.008 DBMET03515 | DBMET03515 | |
| 0.065 | 0.031 | 0.087 | Botulinum neurotoxin type A inhibitor | 0.081 0.016 DBMET01431 0.087 0.013 DBMET03515 | DBMET03515 | |
| 0.05 | 0.017 | 0.052 | Beta adrenoreceptor agonist | 0.052 0.014 DBMET01431 0.047 0.024 DBMET03515 | DBMET01431 | |
| 0.042 | 0.009 | 0.042 | Urotensin II agonist | 0.027 0.018 DBMET01431 0.038 0.01 DBMET03515 | ||
| 0.049 | 0.016 | 0.049 | Glutamate (mGluR group II) antagonist | 0.043 0.022 DBMET01431 | ||
| 0.057 | 0.024 | 0.074 | HCV NS3/NS4A protease inhibitor | 0.049 0.035 DBMET01431 0.074 0.013 DBMET03515 | DBMET03515 | |
| 0.081 | 0.05 | 0.101 | Somatostatin 1 agonist | 0.101 0.033 DBMET03515 | DBMET03515 | |
| 0.05 | 0.018 | 0.065 | Plasmepsin II inhibitor | 0.045 0.022 DBMET01431 0.065 0.01 DBMET03515 | DBMET03515 | |
| 0.055 | 0.023 | 0.06 | Cholesterol esterase inhibitor | 0.06 0.018 DBMET01431 | DBMET01431 | |
| 0.052 | 0.02 | 0.052 | Histamine H2 receptor agonist | 0.041 0.033 DBMET01431 0.047 0.024 DBMET03515 | ||
| 0.045 | 0.014 | 0.064 | Caspase 2 inhibitor | 0.064 0.008 DBMET03515 | DBMET03515 | |
| 0.05 | 0.019 | 0.097 | Cholecystokinin A antagonist | 0.097 0.009 DBMET03515 | DBMET03515 | |
| 0.054 | 0.022 | 0.075 | Carbonic anhydrase IV inhibitor | 0.049 0.025 DBMET01431 0.075 0.013 DBMET03515 | DBMET03515 | |
| 0.039 | 0.008 | 0.052 | 5-Alpha-reductase 2 inhibitor | 0.052 0.007 DBMET01431 | DBMET01431 | |
| 0.057 | 0.026 | 0.078 | Phosphorylase inhibitor | 0.078 0.017 DBMET01431 0.078 0.017 DBMET03515 | DBMET03515 | |
| 0.123 | 0.092 | 0.126 | Nav1.6 sodium channel blocker | 0.126 0.086 DBMET01431 | DBMET01431 | |
| 0.051 | 0.02 | 0.051 | Guanylate cyclase stimulant | |||
| 0.046 | 0.016 | 0.046 | Nicotinic acid receptor 2 agonist | 0.036 0.024 DBMET01431 | ||
| 0.039 | 0.008 | 0.049 | LFA antagonist | 0.031 0.014 DBMET01431 0.049 0.005 DBMET03515 | DBMET03515 | |
| 0.053 | 0.023 | 0.079 | Adenylate cyclase 1 inhibitor | 0.079 0.008 DBMET01431 | DBMET01431 | |
| 0.039 | 0.009 | 0.039 | Purinergic P2Y12 antagonist | |||
| 0.034 | 0.004 | 0.034 | Nicotinic acid receptor 1 antagonist | 0.029 0.004 DBMET01431 | ||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | 0.03 0.013 DBMET01431 | ||
| 0.046 | 0.017 | 0.046 | Aggrecanase 1 inhibitor | |||
| 0.06 | 0.031 | 0.06 | Glucosylceramidase inhibitor | |||
| 0.056 | 0.027 | 0.114 | Aminopeptidase N inhibitor | 0.076 0.018 DBMET01431 0.114 0.01 DBMET03515 | DBMET03515 | |
| 0.036 | 0.007 | 0.05 | Integrin beta5 antagonist | 0.05 0.005 DBMET01431 0.019 0.017 DBMET03515 | DBMET01431 | |
| 0.046 | 0.018 | 0.09 | Calcitonin receptor agonist | 0.037 0.022 DBMET01431 0.09 0.01 DBMET03515 | DBMET03515 | |
| 0.042 | 0.014 | 0.042 | Glutamate (mGluR4) agonist | 0.04 0.016 DBMET01431 | ||
| 0.052 | 0.024 | 0.059 | Cytokine production stimulant | 0.059 0.014 DBMET01431 | DBMET01431 | |
| 0.033 | 0.006 | 0.033 | Acid ceramidase inhibitor | 0.03 0.01 DBMET01431 | ||
| 0.043 | 0.016 | 0.073 | Sirtuin 2 inhibitor | 0.036 0.02 DBMET01431 0.073 0.007 DBMET03515 | DBMET03515 | |
| 0.041 | 0.014 | 0.047 | Peptide deformylase inhibitor | 0.028 0.023 DBMET01431 0.047 0.011 DBMET03515 | DBMET03515 | |
| 0.061 | 0.034 | 0.061 | Lipocortins synthesis agonist | |||
| 0.072 | 0.046 | 0.106 | HIV-1 integrase inhibitor | 0.106 0.022 DBMET01431 | DBMET01431 | |
| 0.063 | 0.037 | 0.063 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.03 | 0.005 | 0.038 | Caspase 8 inhibitor | 0.022 0.009 DBMET01431 0.038 0.004 DBMET03515 | DBMET03515 | |
| 0.038 | 0.012 | 0.038 | Angiotensin AT2 receptor antagonist | |||
| 0.03 | 0.004 | 0.03 | Calcium-dependent phospholipase A2 inhibitor | 0.017 0.005 DBMET03515 | ||
| 0.08 | 0.054 | 0.08 | Acetylcholine nicotinic antagonist | |||
| 0.096 | 0.072 | 0.096 | Estrogen receptor beta antagonist | |||
| 0.047 | 0.022 | 0.05 | Nerve growth factor antagonist | 0.05 0.018 DBMET01431 | DBMET01431 | |
| 0.033 | 0.009 | 0.033 | Retinoid X gamma receptor antagonist | 0.033 0.009 DBMET01431 | ||
| 0.027 | 0.004 | 0.027 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET01431 | ||
| 0.038 | 0.014 | 0.229 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.229 0.004 DBMET01431 | DBMET01431 | |
| 0.035 | 0.012 | 0.035 | NMDA 2D receptor antagonist | 0.025 0.022 DBMET01431 | ||
| 0.048 | 0.025 | 0.067 | Oxytocin agonist | 0.044 0.028 DBMET01431 0.067 0.012 DBMET03515 | DBMET03515 | |
| 0.044 | 0.021 | 0.044 | Histone deacetylase 9 inhibitor | |||
| 0.033 | 0.01 | 0.057 | Integrin alpha2beta1 antagonist | 0.057 0.004 DBMET01431 0.045 0.005 DBMET03515 | DBMET01431 | |
| 0.039 | 0.016 | 0.1 | Liver X receptor beta agonist | 0.1 0.005 DBMET01431 | DBMET01431 | |
| 0.038 | 0.015 | 0.048 | Melatonin receptor 1A agonist | 0.048 0.009 DBMET01431 | DBMET01431 | |
| 0.033 | 0.011 | 0.055 | Calcium-sensing receptor agonist | 0.04 0.008 DBMET01431 0.055 0.005 DBMET03515 | DBMET03515 | |
| 0.029 | 0.006 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.025 0.01 DBMET01431 | ||
| 0.062 | 0.04 | 0.074 | HIV-1 integrase (Strand Transfer) inhibitor | 0.074 0.034 DBMET01431 | DBMET01431 | |
| 0.04 | 0.018 | 0.049 | RNA-directed RNA polymerase inhibitor | 0.049 0.013 DBMET01431 | DBMET01431 | |
| 0.128 | 0.105 | 0.163 | Neuropeptide Y1 antagonist | 0.163 0.047 DBMET03515 | DBMET03515 | |
| 0.026 | 0.004 | 0.059 | Thyroid hormone alpha agonist | 0.059 0.003 DBMET01431 | DBMET01431 | |
| 0.055 | 0.033 | 0.065 | Autotaxin inhibitor | 0.065 0.025 DBMET01431 | DBMET01431 | |
| 0.034 | 0.013 | 0.034 | Caspase 6 inhibitor | 0.03 0.023 DBMET03515 | ||
| 0.05 | 0.029 | 0.177 | Carnitine palmitoyltransferase 1B inhibitor | 0.177 0.003 DBMET01431 | DBMET01431 | |
| 0.026 | 0.005 | 0.026 | Estrogen-related receptor gamma agonist | 0.024 0.006 DBMET01431 | ||
| 0.029 | 0.008 | 0.029 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.016 DBMET01431 | ||
| 0.039 | 0.018 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.039 0.019 DBMET01431 | ||
| 0.035 | 0.015 | 0.035 | Epoxide hydrolase 1 inhibitor | 0.029 0.026 DBMET01431 | ||
| 0.024 | 0.004 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET01431 | ||
| 0.036 | 0.016 | 0.036 | Cholesterol ester transfer protein antagonist | 0.035 0.017 DBMET01431 | ||
| 0.053 | 0.034 | 0.089 | Carbonic anhydrase II stimulant | 0.089 0.007 DBMET03515 | DBMET03515 | |
| 0.027 | 0.008 | 0.069 | Integrin alpha4beta1 antagonist | 0.027 0.008 DBMET01431 0.069 0.004 DBMET03515 | DBMET03515 | |
| 0.05 | 0.031 | 0.107 | AMPA receptor antagonist | 0.107 0.01 DBMET01431 0.092 0.014 DBMET03515 | DBMET01431 | |
| 0.053 | 0.034 | 0.053 | Glucose-6-phosphate translocase inhibitor | |||
| 0.029 | 0.01 | 0.032 | Prostaglandin EP1 antagonist | 0.032 0.009 DBMET01431 | DBMET01431 | |
| 0.104 | 0.086 | 0.104 | Acetylcholine muscarinic antagonist | 0.103 0.087 DBMET01431 | ||
| 0.047 | 0.028 | 0.05 | Dihydroorotase inhibitor | 0.05 0.025 DBMET01431 | DBMET01431 | |
| 0.036 | 0.017 | 0.058 | Cholecystokinin B antagonist | 0.028 0.024 DBMET01431 0.058 0.009 DBMET03515 | DBMET03515 | |
| 0.029 | 0.01 | 0.029 | Complement factor 1s inhibitor | 0.024 0.022 DBMET01431 | ||
| 0.026 | 0.007 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.027 0.006 DBMET01431 0.024 0.009 DBMET03515 | DBMET01431 | |
| 0.063 | 0.045 | 0.074 | Calcium channel P-type blocker | 0.074 0.021 DBMET01431 | DBMET01431 | |
| 0.023 | 0.005 | 0.023 | Angiotensin AT1B receptor antagonist | 0.022 0.005 DBMET01431 | ||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 DBMET01431 | ||
| 0.033 | 0.015 | 0.11 | Liver X receptor alpha antagonist | 0.11 0.004 DBMET01431 | DBMET01431 | |
| 0.021 | 0.004 | 0.032 | Thyroid hormone beta agonist | 0.032 0.003 DBMET01431 | DBMET01431 | |
| 0.059 | 0.042 | 0.101 | Cathepsin E inhibitor | 0.101 0.013 DBMET03515 | DBMET03515 | |
| 0.054 | 0.036 | 0.085 | Matrix metalloproteinase 1 inhibitor | 0.085 0.019 DBMET03515 | DBMET03515 | |
| 0.022 | 0.005 | 0.033 | Egl nine homolog 1 inhibitor | 0.033 0.004 DBMET01431 | DBMET01431 | |
| 0.034 | 0.017 | 0.112 | AMPA 2 receptor antagonist | 0.112 0.005 DBMET01431 0.071 0.008 DBMET03515 | DBMET01431 | |
| 0.038 | 0.022 | 0.08 | p53 inhibitor | 0.08 0.004 DBMET01431 | DBMET01431 | |
| 0.02 | 0.004 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DBMET01431 | ||
| 0.055 | 0.04 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.032 DBMET01431 | DBMET01431 | |
| 0.034 | 0.018 | 0.116 | Liver X receptor antagonist | 0.116 0.005 DBMET01431 | DBMET01431 | |
| 0.02 | 0.004 | 0.02 | Integrin beta6 antagonist | 0.018 0.005 DBMET01431 | ||
| 0.092 | 0.077 | 0.14 | Urease inhibitor | 0.111 0.054 DBMET01431 0.14 0.028 DBMET03515 | DBMET03515 | |
| 0.059 | 0.044 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | 0.062 0.038 DBMET01431 | DBMET01431 | |
| 0.058 | 0.043 | 0.071 | Androgen agonist | 0.071 0.03 DBMET01431 | DBMET01431 | |
| 0.021 | 0.006 | 0.021 | Vitamin D receptor agonist | 0.02 0.007 DBMET01431 | ||
| 0.022 | 0.007 | 0.027 | CXC chemokine 5 receptor antagonist | 0.027 0.005 DBMET01431 | DBMET01431 | |
| 0.03 | 0.015 | 0.046 | Protocollagen prolyl hydroxylase inhibitor | 0.046 0.006 DBMET01431 | DBMET01431 | |
| 0.019 | 0.004 | 0.019 | Integrin alphaVbeta5 antagonist | 0.014 0.005 DBMET01431 0.01 0.007 DBMET03515 | ||
| 0.024 | 0.01 | 0.027 | 5-Alpha-reductase 1 inhibitor | 0.027 0.009 DBMET01431 | DBMET01431 | |
| 0.047 | 0.033 | 0.047 | Potassium channel Kv1.3 blocker | 0.044 0.036 DBMET01431 | ||
| 0.035 | 0.022 | 0.035 | Adenosine uptake inhibitor | |||
| 0.027 | 0.014 | 0.056 | NMDA receptor glycine site antagonist | 0.056 0.005 DBMET01431 | DBMET01431 | |
| 0.041 | 0.028 | 0.099 | Erythropoietin receptor agonist | 0.042 0.027 DBMET01431 0.099 0.01 DBMET03515 | DBMET03515 | |
| 0.03 | 0.017 | 0.033 | Estrogen-related receptor gamma antagonist | 0.033 0.011 DBMET01431 | DBMET01431 | |
| 0.027 | 0.015 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.025 0.02 DBMET01431 | ||
| 0.017 | 0.005 | 0.017 | Carbonic anhydrase XI inhibitor | 0.013 0.008 DBMET01431 | ||
| 0.022 | 0.01 | 0.022 | Retinoic acid beta receptor agonist | 0.02 0.014 DBMET01431 | ||
| 0.068 | 0.055 | 0.07 | Calcium channel L-type blocker | 0.07 0.052 DBMET01431 | DBMET01431 | |
| 0.015 | 0.003 | 0.015 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.012 0.003 DBMET03515 | ||
| 0.078 | 0.067 | 0.078 | Thioredoxin reductase inhibitor | |||
| 0.037 | 0.026 | 0.138 | Factor XIIIa inhibitor | 0.138 0.004 DBMET03515 | DBMET03515 | |
| 0.018 | 0.007 | 0.03 | Integrin alphaVbeta6 antagonist | 0.017 0.007 DBMET01431 0.03 0.004 DBMET03515 | DBMET03515 | |
| 0.029 | 0.018 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.03 0.018 DBMET01431 | DBMET01431 | |
| 0.023 | 0.012 | 0.023 | Angiotensin AT1A receptor antagonist | |||
| 0.07 | 0.059 | 0.07 | Adenosine A3 receptor antagonist | 0.068 0.061 DBMET01431 | ||
| 0.035 | 0.024 | 0.045 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.025 DBMET01431 0.045 0.008 DBMET03515 | DBMET03515 | |
| 0.019 | 0.008 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 DBMET01431 0.02 0.006 DBMET03515 | DBMET01431 | |
| 0.027 | 0.016 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET01431 | ||
| 0.027 | 0.017 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 DBMET01431 | DBMET01431 | |
| 0.059 | 0.048 | 0.069 | HIV-1 integrase (3'-Processing) inhibitor | 0.069 0.039 DBMET01431 | DBMET01431 | |
| 0.103 | 0.092 | 0.103 | Cholinergic antagonist | |||
| 0.026 | 0.016 | 0.033 | Kainate receptor 4 antagonist | 0.024 0.018 DBMET01431 0.033 0.012 DBMET03515 | DBMET03515 | |
| 0.038 | 0.029 | 0.044 | Retinoic acid alpha receptor agonist | 0.044 0.02 DBMET01431 | DBMET01431 | |
| 0.042 | 0.033 | 0.054 | Nicotinic receptor alpha3 subunit antagonist | 0.054 0.022 DBMET03515 | DBMET03515 | |
| 0.028 | 0.018 | 0.043 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.021 DBMET01431 0.043 0.006 DBMET03515 | DBMET03515 | |
| 0.151 | 0.141 | 0.16 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.16 0.131 DBMET01431 | DBMET01431 | |
| 0.029 | 0.02 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.018 DBMET01431 | ||
| 0.028 | 0.019 | 0.032 | Endothelin receptor antagonist | 0.032 0.016 DBMET01431 | DBMET01431 | |
| 0.021 | 0.012 | 0.021 | Toll-Like receptor 8 agonist | |||
| 0.02 | 0.011 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.006 DBMET01431 | DBMET01431 | |
| 0.048 | 0.04 | 0.056 | CXC chemokine 1 receptor antagonist | 0.056 0.027 DBMET01431 | DBMET01431 | |
| 0.031 | 0.023 | 0.041 | HCV NS5B polymerase inhibitor | 0.041 0.014 DBMET01431 | DBMET01431 | |
| 0.011 | 0.003 | 0.013 | Integrin alpha5beta6 antagonist | 0.013 0.003 DBMET01431 | DBMET01431 | |
| 0.017 | 0.01 | 0.017 | Calcium-sensing receptor antagonist | |||
| 0.013 | 0.006 | 0.013 | Carboxypeptidase B2 inhibitor | 0.013 0.006 DBMET03515 | ||
| 0.022 | 0.016 | 0.024 | Beta 1 adrenoreceptor agonist | 0.024 0.014 DBMET01431 | DBMET01431 | |
| 0.022 | 0.016 | 0.031 | Geranylgeranyltransferase inhibitor | 0.031 0.009 DBMET03515 | DBMET03515 | |
| 0.02 | 0.015 | 0.026 | Kainate receptor 5 antagonist | 0.021 0.014 DBMET01431 0.026 0.011 DBMET03515 | DBMET03515 | |
| 0.046 | 0.041 | 0.057 | Collagenase inhibitor | 0.057 0.02 DBMET03515 | DBMET03515 | |
| 0.102 | 0.096 | 0.111 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.072 DBMET01431 | DBMET01431 | |
| 0.171 | 0.165 | 0.205 | 5 Hydroxytryptamine 1E antagonist | 0.205 0.125 DBMET01431 | DBMET01431 | |
| 0.038 | 0.033 | 0.055 | Neurokinin 2 agonist | 0.055 0.015 DBMET03515 | DBMET03515 | |
| 0.017 | 0.012 | 0.02 | Telomerase stimulant | 0.02 0.007 DBMET01431 | DBMET01431 | |
| 0.025 | 0.021 | 0.025 | Toll-Like receptor 4 agonist | |||
| 0.017 | 0.013 | 0.019 | Kainate receptor 3 antagonist | 0.018 0.01 DBMET01431 0.019 0.01 DBMET03515 | DBMET03515 | |
| 0.077 | 0.073 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.099 | 0.094 | 0.099 | Acetylcholine antagonist | |||
| 0.015 | 0.011 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET01431 | DBMET01431 | |
| 0.022 | 0.018 | 0.042 | ICAM 1 antagonist | 0.031 0.006 DBMET01431 0.042 0.004 DBMET03515 | DBMET03515 | |
| 0.021 | 0.018 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.017 DBMET01431 | DBMET01431 | |
| 0.034 | 0.031 | 0.082 | Carbonic anhydrase I stimulant | 0.082 0.006 DBMET03515 | DBMET03515 | |
| 0.008 | 0.005 | 0.008 | Free fatty acid receptor 2 antagonist | |||
| 0.024 | 0.022 | 0.024 | CXC chemokine 2 receptor antagonist | |||
| 0.036 | 0.034 | 0.036 | Histone deacetylase 8 inhibitor | |||
| 0.029 | 0.027 | 0.035 | Elastase 3B inhibitor | 0.035 0.013 DBMET01431 | DBMET01431 | |
| 0.029 | 0.027 | 0.035 | Elastase 3A inhibitor | 0.035 0.013 DBMET01431 | DBMET01431 | |
| 0.029 | 0.027 | 0.035 | Elastase 2B inhibitor | 0.035 0.013 DBMET01431 | DBMET01431 | |
| 0.011 | 0.01 | 0.022 | Integrin beta2 antagonist | 0.014 0.008 DBMET01431 0.022 0.005 DBMET03515 | DBMET03515 | |
| 0.016 | 0.015 | 0.022 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.015 DBMET01431 0.022 0.007 DBMET03515 | DBMET03515 | |
| 0.021 | 0.02 | 0.021 | Retinoic acid receptor agonist | |||
| 0.027 | 0.026 | 0.035 | Plasmepsin I inhibitor | 0.035 0.016 DBMET03515 | DBMET03515 | |
| 0.106 | 0.105 | 0.106 | Cytokine production inhibitor | |||
| 0.03 | 0.029 | 0.03 | Catechol O-methyltransferase inhibitor | |||
| 0.058 | 0.057 | 0.1 | Histone deacetylase SIRT3 inhibitor | 0.1 0.01 DBMET03515 | DBMET03515 | |
| 0.096 | 0.095 | 0.096 | Beta amyloid protein antagonist | 0.096 0.095 DBMET01431 | ||
| 0.04 | 0.04 | 0.042 | Histamine H1 receptor agonist | 0.042 0.034 DBMET01431 | DBMET01431 | |
| 0.039 | 0.039 | 0.173 | Neurotensin receptor antagonist | 0.173 0.008 DBMET03515 | DBMET03515 | |
| 0.033 | 0.033 | 0.04 | Diamine oxidase inhibitor | 0.04 0.023 DBMET01431 | DBMET01431 | |
| 0.06 | 0.061 | 0.185 | Potassium channel large-conductance Ca-activated activator | 0.185 0.007 DBMET01431 0.067 0.047 DBMET03515 | DBMET01431 | |
| 0.009 | 0.01 | 0.011 | Angiotensin AT2 receptor agonist | 0.011 0.006 DBMET03515 | DBMET03515 | |
| 0.01 | 0.012 | 0.014 | Egl nine homolog 3 inhibitor | 0.014 0.006 DBMET01431 | DBMET01431 | |
| 0.042 | 0.044 | 0.049 | Aldosterone antagonist | 0.049 0.03 DBMET01431 | DBMET01431 | |
| 0.047 | 0.049 | 0.052 | Xanthine dehydrogenase inhibitor | 0.052 0.044 DBMET01431 | DBMET01431 | |
| 0.056 | 0.059 | 0.091 | Trypsin inhibitor | 0.058 0.054 DBMET01431 0.091 0.021 DBMET03515 | DBMET03515 | |
| 0.009 | 0.012 | 0.011 | Thrombopoietin agonist | 0.011 0.01 DBMET01431 | DBMET01431 | |
| 0.019 | 0.022 | 0.028 | Aminopeptidase P inhibitor | 0.028 0.012 DBMET03515 | DBMET03515 | |
| 0.044 | 0.048 | 0.05 | Squalene epoxidase inhibitor | 0.05 0.034 DBMET01431 | DBMET01431 | |
| 0.015 | 0.019 | 0.027 | Neurokinin 1 agonist | 0.027 0.011 DBMET03515 | DBMET03515 | |
| 0.04 | 0.044 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 DBMET03515 | DBMET03515 | |
| 0.011 | 0.016 | 0.013 | Adenosine A2a receptor agonist | 0.013 0.012 DBMET01431 | DBMET01431 | |
| 0.025 | 0.03 | 0.03 | Endothelial nitric-oxide synthase inhibitor | 0.03 0.023 DBMET03515 | DBMET03515 | |
| 0.097 | 0.103 | 0.333 | Cyclooxygenase 1 inhibitor | 0.333 0.011 DBMET01431 | DBMET01431 | |
| 0.025 | 0.032 | 0.046 | Trypsin I inhibitor | 0.046 0.014 DBMET03515 | DBMET03515 | |
| 0.013 | 0.02 | 0.073 | Cholecystokinin agonist | 0.073 0.005 DBMET03515 | DBMET03515 | |
| 0.124 | 0.131 | 0.195 | Amyloid beta aggregation inhibitor | 0.195 0.08 DBMET03515 | DBMET03515 | |
| 0.007 | 0.015 | 0.011 | Beta 3 adrenoreceptor agonist | 0.011 0.009 DBMET01431 | DBMET01431 | |
| 0.023 | 0.031 | 0.047 | Thrombin receptor antagonist | 0.047 0.01 DBMET03515 | DBMET03515 | |
| 0.012 | 0.019 | 0.054 | Cholecystokinin A agonist | 0.054 0.005 DBMET03515 | DBMET03515 | |
| 0.005 | 0.013 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET01431 | DBMET01431 | |
| 0.131 | 0.139 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | 0.173 0.071 DBMET01431 0.139 0.122 DBMET03515 | DBMET01431 | |
| 0.057 | 0.066 | 0.134 | Sirtuin 1 inhibitor | 0.134 0.01 DBMET03515 | DBMET03515 | |
| 0.055 | 0.064 | 0.069 | Histone deacetylase inhibitor | 0.069 0.041 DBMET03515 | DBMET03515 | |
| 0.043 | 0.053 | 0.136 | Human rhinovirus A protease inhibitor | 0.136 0.01 DBMET03515 | DBMET03515 | |
| 0.018 | 0.028 | 0.022 | Bombesin agonist | 0.022 0.015 DBMET01431 0.021 0.017 DBMET03515 | DBMET01431 | |
| 0.026 | 0.037 | 0.029 | Dipeptidyl peptidase II inhibitor | 0.029 0.028 DBMET03515 | DBMET03515 | |
| 0.076 | 0.087 | 0.101 | Aminoacyl-tRNA synthetase inhibitor | 0.101 0.044 DBMET03515 | DBMET03515 | |
| 0.032 | 0.044 | 0.054 | Growth hormone release inhibitor | 0.054 0.019 DBMET03515 | DBMET03515 | |
| 0.015 | 0.026 | 0.022 | Growth hormone releasing factor antagonist | 0.022 0.018 DBMET03515 | DBMET03515 | |
| 0.014 | 0.026 | 0.019 | Retinoic acid alpha receptor antagonist | 0.019 0.016 DBMET01431 | DBMET01431 | |
| 0.014 | 0.026 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.013 DBMET01431 | DBMET01431 | |
| 0.019 | 0.031 | 0.034 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.034 0.014 DBMET01431 | DBMET01431 | |
| 0.06 | 0.073 | 0.072 | Secretase beta inhibitor | 0.072 0.046 DBMET03515 | DBMET03515 | |
| 0.087 | 0.101 | 0.144 | Interleukin 1b antagonist | 0.144 0.045 DBMET01431 | DBMET01431 | |
| 0.034 | 0.048 | 0.056 | HIV-1 protease inhibitor | 0.056 0.015 DBMET03515 | DBMET03515 | |
| 0.029 | 0.044 | 0.035 | HCV polyprotein inhibitor | 0.035 0.02 DBMET03515 | DBMET03515 | |
| 0.101 | 0.116 | 0.136 | Alkaline phosphatase inhibitor | 0.136 0.07 DBMET01431 | DBMET01431 | |
| 0.034 | 0.051 | 0.101 | Liver X receptor agonist | 0.101 0.007 DBMET01431 | DBMET01431 | |
| 0.026 | 0.042 | 0.039 | Somatostatin 1 antagonist | 0.039 0.027 DBMET03515 | DBMET03515 | |
| 0.04 | 0.057 | 0.06 | Topoisomerase II beta inhibitor | 0.06 0.022 DBMET01431 | DBMET01431 | |
| 0.034 | 0.051 | 0.041 | Stearoyl-CoA desaturase inhibitor | 0.041 0.036 DBMET01431 | DBMET01431 | |
| 0.01 | 0.027 | 0.015 | CXC chemokine 4 receptor agonist | 0.015 0.011 DBMET03515 | DBMET03515 | |
| 0.009 | 0.027 | 0.019 | Carbonic anhydrase IV stimulant | 0.019 0.007 DBMET03515 | DBMET03515 | |
| 0.026 | 0.044 | 0.064 | Melanocortin 1 antagonist | 0.064 0.016 DBMET03515 | DBMET03515 | |
| 0.027 | 0.046 | 0.034 | AMPA receptor agonist | 0.034 0.026 DBMET01431 | DBMET01431 | |
| 0.008 | 0.028 | 0.015 | Integrin alphaLbeta2 antagonist | 0.015 0.007 DBMET03515 | DBMET03515 | |
| 0.039 | 0.06 | 0.054 | Plasminogen activator inhibitor | 0.054 0.044 DBMET01431 0.054 0.044 DBMET03515 | DBMET03515 | |
| 0.025 | 0.047 | 0.036 | TRPM8 blocker | 0.036 0.03 DBMET01431 | DBMET01431 | |
| 0.059 | 0.082 | 0.1 | Analgesic, opioid | 0.1 0.031 DBMET03515 | DBMET03515 | |
| 0.005 | 0.03 | 0.013 | Glucagon agonist | 0.013 0.011 DBMET03515 | DBMET03515 | |
| 0.019 | 0.046 | 0.055 | Carnitine palmitoyltransferase 1A inhibitor | 0.055 0.006 DBMET01431 | DBMET01431 | |
| 0.037 | 0.065 | 0.044 | Parathyroid hormone antagonist | 0.044 0.036 DBMET03515 | DBMET03515 | |
| 0.031 | 0.06 | 0.049 | Glutamate (mGluR group I) agonist | 0.049 0.032 DBMET01431 | DBMET01431 | |
| 0.068 | 0.098 | 0.153 | Factor XII inhibitor | 0.153 0.012 DBMET03515 | DBMET03515 | |
| 0.024 | 0.055 | 0.038 | Calpain 1 inhibitor | 0.038 0.013 DBMET03515 | DBMET03515 | |
| 0.038 | 0.07 | 0.134 | Opioid delta receptor antagonist | 0.134 0.023 DBMET03515 | DBMET03515 | |
| 0.037 | 0.07 | 0.098 | Cathepsin D inhibitor | 0.098 0.019 DBMET03515 | DBMET03515 | |
| 0.038 | 0.07 | 0.095 | Cathepsin L inhibitor | 0.095 0.021 DBMET03515 | DBMET03515 | |
| 0.033 | 0.066 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.036 DBMET01431 | DBMET01431 | |
| 0.074 | 0.112 | 0.112 | Protein kinase (CK2) alpha inhibitor | 0.112 0.067 DBMET01431 | DBMET01431 | |
| 0.029 | 0.068 | 0.047 | Plasmin inhibitor | 0.047 0.034 DBMET03515 | DBMET03515 | |
| 0.023 | 0.061 | 0.035 | Tryptase inhibitor | 0.035 0.03 DBMET03515 | DBMET03515 | |
| 0.035 | 0.075 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 DBMET01431 | DBMET01431 | |
| 0.032 | 0.073 | 0.074 | Farnesyltransferase inhibitor | 0.074 0.014 DBMET03515 | DBMET03515 | |
| 0.062 | 0.102 | 0.147 | Opioid antagonist | 0.147 0.027 DBMET03515 | DBMET03515 | |
| 0.041 | 0.082 | 0.114 | Opioid mu receptor antagonist | 0.114 0.027 DBMET03515 | DBMET03515 | |
| 0.07 | 0.113 | 0.098 | 3C-Like protease (SARS coronavirus) inhibitor | 0.098 0.035 DBMET03515 | DBMET03515 | |
| 0.094 | 0.139 | 0.142 | Interleukin 1 antagonist | 0.142 0.063 DBMET01431 | DBMET01431 | |
| 0.019 | 0.064 | 0.053 | Cathepsin L2 inhibitor | 0.053 0.021 DBMET03515 | DBMET03515 | |
| 0.013 | 0.06 | 0.038 | Factor VII inhibitor | 0.038 0.015 DBMET03515 | DBMET03515 | |
| 0.038 | 0.086 | 0.071 | Cathepsin B inhibitor | 0.071 0.028 DBMET03515 | DBMET03515 | |
| 0.021 | 0.069 | 0.06 | Somatostatin 5 agonist | 0.06 0.009 DBMET03515 | DBMET03515 | |
| 0.028 | 0.076 | 0.149 | Neuropeptide agonist | 0.149 0.013 DBMET03515 | DBMET03515 | |
| 0.008 | 0.058 | 0.027 | Human T-cell leukemia virus type I protease inhibitor | 0.027 0.009 DBMET03515 | DBMET03515 | |
| 0.046 | 0.097 | 0.062 | Neuraminidase (influenza) inhibitor | 0.062 0.049 DBMET03515 | DBMET03515 | |
| 0.016 | 0.067 | 0.027 | Trypsin II inhibitor | 0.027 0.025 DBMET03515 | DBMET03515 | |
| 0.026 | 0.082 | 0.062 | Opioid mu receptor agonist | 0.062 0.023 DBMET03515 | DBMET03515 | |
| 0.088 | 0.145 | 0.31 | Cyclooxygenase inhibitor | 0.31 0.016 DBMET01431 | DBMET01431 | |
| 0.013 | 0.074 | 0.049 | Bradykinin B2 receptor agonist | 0.049 0.008 DBMET03515 | DBMET03515 | |
| 0.005 | 0.066 | 0.027 | Melanocortin 3 antagonist | 0.027 0.021 DBMET03515 | DBMET03515 | |
| 0.009 | 0.07 | 0.023 | Complement factor D inhibitor | 0.023 0.005 DBMET01431 | DBMET01431 | |
| 0.032 | 0.095 | 0.055 | Neuraminidase inhibitor | 0.055 0.05 DBMET03515 | DBMET03515 | |
| 0.03 | 0.096 | 0.069 | Bombesin antagonist | 0.069 0.013 DBMET03515 | DBMET03515 | |
| 0.02 | 0.087 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 DBMET01431 | DBMET01431 | |
| 0.066 | 0.135 | 0.097 | 5 Hydroxytryptamine 3A agonist | 0.097 0.079 DBMET01431 | DBMET01431 | |
| 0.015 | 0.084 | 0.037 | Cathepsin L1 inhibitor | 0.037 0.03 DBMET03515 | DBMET03515 | |
| 0.044 | 0.12 | 0.099 | Thrombin inhibitor | 0.099 0.026 DBMET03515 | DBMET03515 | |
| 0.022 | 0.102 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.025 DBMET01431 | DBMET01431 | |
| 0.048 | 0.137 | 0.085 | Protein kinase (CK2) inhibitor | 0.085 0.077 DBMET01431 | DBMET01431 | |
| 0.066 | 0.157 | 0.136 | Glutamate receptor antagonist | 0.136 0.061 DBMET01431 | DBMET01431 | |
| 0.079 | 0.17 | 0.129 | Cytidine deaminase inhibitor | 0.129 0.092 DBMET01431 | DBMET01431 | |
| 0.011 | 0.103 | 0.045 | Growth hormone releasing factor agonist | 0.045 0.015 DBMET03515 | DBMET03515 | |
| 0.038 | 0.131 | 0.071 | Kallikrein 1 inhibitor | 0.071 0.023 DBMET03515 | DBMET03515 | |
| 0.048 | 0.149 | 0.086 | Opioid kappa receptor antagonist | 0.086 0.05 DBMET03515 | DBMET03515 | |
| 0.013 | 0.116 | 0.034 | Opioid delta receptor agonist | 0.034 0.027 DBMET03515 | DBMET03515 | |
| 0.013 | 0.12 | 0.051 | Melanocortin 4 antagonist | 0.051 0.023 DBMET03515 | DBMET03515 | |
| 0.018 | 0.129 | 0.061 | Opioid agonist | 0.061 0.029 DBMET03515 | DBMET03515 | |
| 0.013 | 0.123 | 0.064 | Factor VIIa inhibitor | 0.064 0.016 DBMET03515 | DBMET03515 | |
| 0.03 | 0.144 | 0.064 | Bombesin 3 receptor antagonist | 0.064 0.029 DBMET03515 | DBMET03515 | |
| 0.097 | 0.221 | 0.133 | MAP kinase 3 inhibitor | 0.133 0.099 DBMET01431 | DBMET01431 | |
| 0.017 | 0.143 | 0.055 | Melanocortin antagonist | 0.055 0.025 DBMET03515 | DBMET03515 | |
| 0.017 | 0.148 | 0.031 | Vasopressin 1A agonist | 0.031 0.014 DBMET03515 | DBMET03515 | |
| 0.054 | 0.194 | 0.21 | Cyclooxygenase 2 inhibitor | 0.21 0.028 DBMET01431 | DBMET01431 | |
| 0.021 | 0.161 | 0.057 | Cyclin A1 inhibitor | 0.057 0.044 DBMET03515 | DBMET03515 | |
| 0.037 | 0.189 | 0.063 | Gonadotropin-releasing hormone receptor agonist | 0.063 0.034 DBMET03515 | DBMET03515 | |
| 0.025 | 0.18 | 0.066 | Phosphodiesterase 4B inhibitor | 0.066 0.048 DBMET01431 | DBMET01431 | |
| 0.01 | 0.168 | 0.021 | Vasopressin 1 agonist | 0.021 0.016 DBMET03515 | DBMET03515 | |
| 0.004 | 0.162 | 0.016 | KiSS-1 receptor antagonist | 0.016 0.014 DBMET03515 | DBMET03515 | |
| 0.045 | 0.212 | 0.089 | Falcipain inhibitor | 0.089 0.063 DBMET03515 | DBMET03515 | |
| 0.044 | 0.215 | 0.084 | Falcipain 2 inhibitor | 0.084 0.065 DBMET03515 | DBMET03515 | |
| 0.019 | 0.197 | 0.046 | GHS receptor agonist | 0.046 0.024 DBMET03515 | DBMET03515 | |
| 0.007 | 0.198 | 0.107 | Protease activated receptor 1 antagonist | 0.107 0.013 DBMET03515 | DBMET03515 | |
| 0.016 | 0.21 | 0.049 | Kallikrein inhibitor | 0.049 0.031 DBMET03515 | DBMET03515 | |
| 0.025 | 0.226 | 0.129 | Bombesin 1 receptor agonist | 0.129 0.011 DBMET03515 | DBMET03515 | |
| 0.019 | 0.247 | 0.112 | Histone deacetylase SIRT2 inhibitor | 0.112 0.02 DBMET03515 | DBMET03515 | |
| 0.009 | 0.245 | 0.038 | Bombesin 1 receptor antagonist | 0.038 0.025 DBMET03515 | DBMET03515 | |
| 0.015 | 0.271 | 0.12 | Phosphodiesterase 4D inhibitor | 0.12 0.028 DBMET01431 | DBMET01431 | |
| 0.101 | 0.422 | 0.227 | Analgesic | 0.227 0.206 DBMET01431 | DBMET01431 | |
| 0.008 | 0.354 | 0.027 | Antidiuretic hormone agonist | 0.027 0.019 DBMET03515 | DBMET03515 | |
| 0.005 | 0.37 | 0.04 | Secretase gamma inhibitor | 0.04 0.032 DBMET03515 | DBMET03515 | |
| 0.097 | 0.525 | 0.298 | Ca(v)3.3 blocker | 0.298 0.044 DBMET03515 | DBMET03515 | |
| 0.005 | 0.479 | 0.064 | Protease activated receptor antagonist | 0.064 0.041 DBMET03515 | DBMET03515 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |